Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1050.Time spend outdoors in summer,47967,0.0742238455968984,0.0372448155924233,0.00122400703574869,0.147223684158048,0.0462878985645777
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1060.Time spent outdoors in winter,44389,0.0283940984852148,0.0425716379551937,-0.0550463119069648,0.111834508877394,0.504797618213588
EPHA2,Ephrin type-A receptor 2,Physical activities,X1070.Time spent watching television (TV),49490,0.244151053478516,0.0386318510166142,0.168432625485952,0.31986948147108,2.6606854176062e-10
EPHA2,Ephrin type-A receptor 2,Physical activities,X1080.Time spent using computer,44384,-0.156569006894206,0.039679717070835,-0.234341252353043,-0.0787967614353697,7.98000132149684e-05
EPHA2,Ephrin type-A receptor 2,Physical activities,X1090.Time spent driving,41853,-0.196348190226153,0.0443176654417707,-0.283210814492024,-0.109485565960283,9.46008482702369e-06
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1160.Sleep duration,50955,0.0345942612038072,0.0343348777885267,-0.0327020992617052,0.10189062166932,0.313677572216633
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,33730,0.00350903921541219,0.0105437417223572,-0.017156694560408,0.0241747729912324,0.739286908800648
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,33730,0.00708734292127305,0.00941921687605312,-0.0113743221557911,0.0255490079983372,0.451808946999182
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,33730,0.0385865260363634,0.0112194312053312,0.0165964408739143,0.0605766111988125,0.000585874886885581
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,33730,0.0170260653593108,0.0116026934896579,-0.00571521388041862,0.0397673445990402,0.142294775478736
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,33730,0.0292882745617255,0.0116520643995348,0.00645022833863727,0.0521263207848136,0.0119684191768659
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,33730,0.0094884265451763,0.0223900170643571,-0.0343960069009637,0.0533728599913162,0.671736574301063
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,33730,0.0256903027865667,0.0220877292832147,-0.0176016466085342,0.0689822521816676,0.244817653862364
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,33730,0.0146143974781962,0.0169735950474043,-0.0186538488147161,0.0478826437711086,0.38925600508221
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,33730,0.0466187627475083,0.0121927917587273,0.0227208909004028,0.0705166345946139,0.000132448173779981
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,33730,0.0131237115794188,0.00847374050962605,-0.00348481981944825,0.0297322429782859,0.121475767275248
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,33730,0.0151271475047313,0.0118237653516261,-0.00804743258445597,0.0383017275939185,0.200793522804116
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,33730,0.0132535871033579,0.00724120478616294,-0.000939174277521423,0.0274463484842373,0.0672369480762112
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,33730,-0.000902884551482113,0.00903935616872424,-0.0186200226421816,0.0168142535392174,0.920438796589031
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,33730,0.0313451300728775,0.0129447960032611,0.00597332990648578,0.0567169302392693,0.0154779301035912
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,33730,0.0276623483065377,0.0123979756842949,0.00336231596531965,0.0519623806477557,0.0256917644781548
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,33730,0.0270985553627885,0.0174761342651796,-0.00715466779696353,0.0613517785225405,0.121030835059252
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,33730,0.00784119877493649,0.0163007627458463,-0.0241082962069222,0.0397906937567951,0.630504651387506
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,33730,0.016288740150374,0.00960268646625828,-0.00253252532349223,0.0351100056242402,0.0898684795426127
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,33730,0.0214680750721174,0.00897889394082315,0.00386944294810405,0.0390667071961308,0.0168247093028731
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,33730,0.0319081051770956,0.0119526870016945,0.00848083865377432,0.0553353717004169,0.00760888318491306
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120040.Fatigue severity over the past week,33735,0.114786593985643,0.0648126697751555,-0.0122462387736618,0.241819426744948,0.0765849057477658
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,33732,0.155571634174194,0.0643213492272323,0.029501789688819,0.28164147865957,0.0155968066137885
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,33733,0.121208478378236,0.0687731487864073,-0.0135868932431219,0.256003849999595,0.07802807512335
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120098.Mobility problems today,33739,0.328933585063206,0.0759216693132873,0.180127113209163,0.477740056917249,1.48950460802415e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120099.Self-care problems today,33739,0.403860763523594,0.116603395307055,0.175318108721765,0.632403418325422,0.000535518555286053
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120100.Problems doing usual activities,33739,0.300631207202462,0.0718168411376236,0.15987019857272,0.441392215832204,2.86428667825689e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120101.Pain or discomfort today,33739,0.196030236336352,0.0650508323145094,0.0685306049999138,0.323529867672791,0.0025895566403846
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120102.Anxiety or depression today,33739,0.128438284196105,0.0757144239793664,-0.0199619868034531,0.276838555195663,0.0898528382142044
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120103.Scale to indicate how health is today,33703,-0.00885826278533895,0.0031213364907358,-0.0149760823071811,-0.00274044326349678,0.0045500113724113
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,33714,0.142373824441548,0.077635313795629,-0.00979139059788525,0.29453903948098,0.0667039304074737
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",33692,0.0770029332489262,0.0784203434330334,-0.0767009398798192,0.230706806377672,0.326162277373761
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",33722,0.0350603038151453,0.0636628135799425,-0.0897188108015419,0.159839418431833,0.581839777178353
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,33716,0.110845184253567,0.0656603084036523,-0.0178490202175915,0.239539388724726,0.0914139571585701
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,33724,0.192010007679498,0.0790811616405188,0.0370109308640812,0.347009084494915,0.0152007461905138
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,33695,0.0467361525278716,0.0825861799436487,-0.11513276016168,0.208605065217423,0.571470289289672
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,33719,0.134124925498808,0.0849726206194188,-0.0324214109152532,0.300671261912868,0.114496695468642
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,33713,0.332480219744376,0.121558895844564,0.094224783889031,0.570735655599721,0.00624730418635041
EPHA2,Ephrin type-A receptor 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,33675,0.348556138303462,0.165209498241436,0.0247455217502469,0.672366754856677,0.0349039510993946
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31451,0.351501069346818,0.0832433532216414,0.188344097032401,0.514658041661235,2.44589514893807e-05
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,48704,0.139337956105804,0.0793751127169879,-0.0162372648194921,0.294913177031101,0.0791973277858457
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,46905,-0.00494044562648968,0.0538362674919996,-0.110459529910809,0.100578638657829,0.926883202050652
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1289.Cooked vegetable intake,50447,-0.280816726660151,0.0356320821310482,-0.350655607637006,-0.210977845683297,3.37405069135128e-15
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,49968,-0.205031516938456,0.0384573627607387,-0.280407947949504,-0.129655085927408,9.82873477670473e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1309.Fresh fruit intake,50481,-0.00376478079988445,0.0370288737872866,-0.0763413734229661,0.0688118118231972,0.919018215087966
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1319.Dried fruit intake,48808,-0.0512410600453996,0.0374061657347895,-0.124557144885587,0.0220750247947878,0.170744489836697
EPHA2,Ephrin type-A receptor 2,Health and medical history,X134.Number of self-reported cancers,51237,0.379818008853728,0.0576349832286151,0.266853441725642,0.492782575981814,4.47807768097702e-11
EPHA2,Ephrin type-A receptor 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,51237,0.371258345021768,0.0366276898617089,0.299468072892818,0.443048617150717,4.22726671943694e-24
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X136.Number of operations, self-reported",51237,0.0974216273711742,0.0361267875819319,0.0266131237105875,0.168230131031761,0.00700827426248749
EPHA2,Ephrin type-A receptor 2,Health and medical history,X137.Number of treatments or medications taken,51237,0.396273124443902,0.0357461174847799,0.326210734173734,0.466335514714071,1.69665506357783e-28
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1438.Bread intake,50327,0.0118304787988075,0.00224695589850782,0.00742644523773212,0.0162345123598828,1.4122035042685e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1458.Cereal intake,49879,0.133479180408467,0.0355635598625438,0.0637746030778814,0.203183757739053,0.000174939876321446
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1488.Tea intake,50345,0.00561075276035693,0.00207893967455577,0.00153603099822761,0.00968547452248624,0.00696240191892862
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1498.Coffee intake,49130,-0.19016229092818,0.035891218479775,-0.260509079148538,-0.119815502707821,1.17890791957668e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X1528.Water intake,49547,-0.107474921905482,0.0361010790213626,-0.178233036787353,-0.0367168070236114,0.00291308917560349
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1568.Average weekly red wine intake,40808,-0.441231577348174,0.0463459063198519,-0.532069553735084,-0.350393600961264,1.96043958347489e-21
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,40806,-0.251308942465518,0.0464438470474245,-0.34233888267847,-0.160279002252566,6.35458038737201e-08
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,40827,0.0702633724427223,0.057869847948971,-0.0431615295372608,0.183688274422705,0.224703365240708
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1598.Average weekly spirits intake,40761,0.0400281254625665,0.0512950767080385,-0.060510224885189,0.140566475810322,0.435196073989409
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1608.Average weekly fortified wine intake,40835,0.222996538520767,0.076346733223545,0.0733569414026184,0.372636135638915,0.00349566030670759
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X1737.Childhood sunburn occasions,44859,-0.142599013757855,0.0430594040570491,-0.226995445709672,-0.0582025818060393,0.000928982229252882
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1807.Father's age at death,44035,-0.00233880769148205,0.00243382644733467,-0.007109107528258,0.0024314921452939,0.336584593735843
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1845.Mother's age,34877,-0.00767260081750166,0.00532146365119952,-0.0181026695738527,0.00275746793884941,0.149382768427642
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1873.Number of full brothers,50745,0.0185463393661953,0.0343313889008331,-0.0487431828794376,0.0858358616118283,0.589053182070249
EPHA2,Ephrin type-A receptor 2,Health and medical history,X1883.Number of full sisters,50750,-0.00999289276409744,0.0344379338608318,-0.0774912431313279,0.057505457603133,0.771687640914272
EPHA2,Ephrin type-A receptor 2,Physical measures,X20015.Sitting height,51057,0.00157151727518879,0.0027632533640135,-0.00384445931827768,0.00698749386865526,0.569551017060516
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20016.Fluid intelligence score,33063,-0.171083581149517,0.057913785588244,-0.284594600902475,-0.0575725613965589,0.00314423636219217
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20018.Prospective memory result,33390,0.169043363662138,0.0737949731040419,0.0244052163782161,0.313681510946061,0.0220029872197051
EPHA2,Ephrin type-A receptor 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32941,0.0116688836028495,0.00376035265054671,0.00429859240777793,0.019039174797921,0.00192111087393638
EPHA2,Ephrin type-A receptor 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32917,0.0058051253706584,0.00374392854697461,-0.00153297458141183,0.0131432253227286,0.121048421487926
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20023.Mean time to correctly identify matches,50938,0.0133686570092229,0.00226366884379043,0.00893186607539361,0.0178054479430521,3.55332418457476e-09
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,48110,-0.00567080140241596,0.00460202139245833,-0.0146907633316343,0.00334916052680237,0.217871159075389
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,47700,-0.00293669893380984,0.00992445829329909,-0.022388637188676,0.0165152393210564,0.767305113657573
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47670,0.00079002988301402,0.0135876192818926,-0.0258417039094954,0.0274217636755234,0.953634934314836
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,47684,0.0021597767832608,0.0109816365699363,-0.0193642308938143,0.0236837844603359,0.844086202931508
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,47688,0.00560195942357721,0.00822011367064011,-0.0105094633708774,0.0217133822180318,0.495565655670183
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#2.Illnesses of father_Stroke,47850,0.00552808320745996,0.00597368327685717,-0.0061803360151801,0.0172365024301,0.354764228154197
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,47787,-0.00315693155565808,0.00752691024409682,-0.0179096756340879,0.0115958125227717,0.674913569813977
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,47695,0.00677514586551116,0.00963389854823102,-0.0121072952890216,0.025657587020044,0.481900106803243
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,47837,-0.000627431136276872,0.00674915031918227,-0.0138557657618741,0.0126009034893204,0.925932589580309
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,47897,-0.00315825847050635,0.00511960264988139,-0.0131926796642739,0.00687616272326118,0.537309821567121
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,47769,0.00567614219883071,0.00713112483487014,-0.00830086247751477,0.0196531468751762,0.426059143809755
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49443,0.00890954567669463,0.00514126500741573,-0.00116733373784019,0.0189864250912294,0.083117220896251
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49316,-0.0088357077460603,0.00749113154145197,-0.0235183255673062,0.00584691007518556,0.238214773437022
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49249,0.00691196545431521,0.0160378783764251,-0.0245222761634779,0.0383462070721083,0.666488443892059
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49286,0.00822540037882752,0.0080557853308547,-0.00756393886964769,0.0240147396273027,0.307238299201277
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,49377,0.00945193798900995,0.00591294309717672,-0.00213743048145642,0.0210413064594763,0.109940718478726
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49273,-0.00817397022463348,0.0108545687424459,-0.0294489249598275,0.0131009845105606,0.451430485511453
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49267,-0.0145459912917715,0.00970939351281877,-0.0335764025768963,0.00448441999335325,0.134110657207693
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49295,0.00939205286933148,0.00770426861368176,-0.00570831361348476,0.0244924193521477,0.222828701006307
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49308,0.0243806662556612,0.00859218391886699,0.00753998577468186,0.0412213467366405,0.00454994354848504
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49466,-0.00316511065837957,0.00446397830543262,-0.0119145081370275,0.00558428682026836,0.478310227350874
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49326,0.011943267873586,0.00702149302453993,-0.00181885845451224,0.0257053942016843,0.0889632892113157
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,45953,0.00147284438341429,0.0072208684729404,-0.0126800578235489,0.0156257465903775,0.838378457345906
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,45814,0.0179985788091313,0.0279596109750234,-0.0368022587019146,0.0727994163201772,0.5197542321791
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,45810,0.0115256858889379,0.0294397214066856,-0.0461761680681659,0.0692275398460418,0.695430716813483
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,45870,0.0153539923930294,0.00797210940296777,-0.000271342036787444,0.0309793268228462,0.0541221414870909
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,45826,0.00998048891583404,0.0167859242629414,-0.0229199226395311,0.0428809004711992,0.552133968589408
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,45839,0.0320163001762589,0.0123282471782784,0.00785293570683329,0.0561796646456846,0.00941098043937422
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,45820,0.00994182243188521,0.0149712610211721,-0.019401849169612,0.0392854940333825,0.506658782758692
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,45818,0.0045993792502414,0.0145224282079266,-0.0238645800372948,0.0330633385377776,0.751467746583067
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,45838,0.00905316705042515,0.0106462340620908,-0.0118134517112728,0.0299197858121231,0.395132636987932
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,45840,0.0195452598221668,0.0127802832724273,-0.00550409539179069,0.0445946150361243,0.126197654052988
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46023,0.00243558514216586,0.00534544011394019,-0.00804147748115691,0.0129126477654886,0.648654966448969
EPHA2,Ephrin type-A receptor 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,45910,0.0184599401472057,0.00766934662982174,0.00342802075275505,0.0334918595416563,0.0160935790720839
EPHA2,Ephrin type-A receptor 2,Mental health,X20127.Neuroticism score,45495,0.129444554460461,0.0365429424825553,0.0578203871946532,0.20106872172627,0.000397574812356917
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,33063,-0.0334325888940681,0.059179880428029,-0.149425154533005,0.0825599767448688,0.572134974397835
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X20161.Pack years of smoking,31566,0.0193126770390132,0.00466177696129857,0.010175594194868,0.0284497598831584,3.47107366238447e-05
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31566,0.0178464916552584,0.00460169634559509,0.008827166817892,0.0268658164926247,0.000106162176895598
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20191.Fluid intelligence score,31247,0.0372907634166632,0.0670843954734596,-0.0941946517113176,0.168776178544644,0.57831235035595
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31247,0.00353259575647399,0.068574473615012,-0.13087337252895,0.137938564041898,0.958916878431891
EPHA2,Ephrin type-A receptor 2,Cognitive function,X20240.Maximum digits remembered correctly,30526,-0.0687452730655292,0.0720672628220479,-0.209997108196743,0.0725065620656846,0.340170088104122
EPHA2,Ephrin type-A receptor 2,Physical measures,X20255.Spirometry QC measure,45039,0.0534350853612164,0.0473742754324261,-0.0394184944863387,0.146288665208771,0.259360675236634
EPHA2,Ephrin type-A receptor 2,Eye measures,X20261.avMSE,30276,0.000738702236972309,0.00427932624641432,-0.00764877720599975,0.00912618167994437,0.862955220915016
EPHA2,Ephrin type-A receptor 2,Eye measures,X20262.Myopia diagnosis,30276,-0.0433039426075693,0.0890735268970675,-0.217888055325822,0.131280170110683,0.626872367694173
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X20280.Glucose-lactate,39716,0.000931852743785517,0.00293569570567398,-0.00482211083933549,0.00668581632690652,0.750928186382691
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,39753,0.00683730208488831,0.00280030713220175,0.00134870010577287,0.0123259040640037,0.0146325419672317
EPHA2,Ephrin type-A receptor 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32855,-0.0148321965577177,0.0133100872154315,-0.0409199674999635,0.0112555743845281,0.265157686017201
EPHA2,Ephrin type-A receptor 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32852,-0.0176903469233912,0.0248419772112872,-0.0663806222575141,0.0309999284107317,0.476413285901655
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32850,-0.000397628587249087,0.0310395187589262,-0.0612350853547445,0.0604398281802463,0.989779365113841
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32850,-0.0293817298894799,0.012532542337232,-0.0539455128704547,-0.00481794690850513,0.0190791084933754
EPHA2,Ephrin type-A receptor 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32850,-0.068581765214096,0.0247469186801707,-0.117085725827231,-0.0200778046009615,0.00559514562494374
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32856,-0.0440238677398488,0.0304026069598332,-0.103612977381122,0.0155652419014242,0.147646141774536
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32856,-0.0434823707446892,0.0201420916258064,-0.0829608703312697,-0.00400387115810867,0.0308953550821335
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32856,-0.0355032490888451,0.0222340624424349,-0.0790820114760174,0.00807551329832722,0.110348914872431
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32856,-0.0222606411230169,0.0366874346309229,-0.0941680129996257,0.0496467307535919,0.544023452954043
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32856,0.0217676082182378,0.0446119080633077,-0.0656717315858453,0.109206948022321,0.625610249149094
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32856,0.000422747993087295,0.0231663532873741,-0.044983304450166,0.0458288004363406,0.985441155219322
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32856,-0.0185586368463292,0.0442523970666402,-0.105293335096944,0.0681760614042856,0.674948058531381
EPHA2,Ephrin type-A receptor 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32856,-0.0451211504670557,0.0305022256561952,-0.104905512753198,0.0146632118190868,0.139104570139276
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32857,0.0198927151151585,0.0358740359571033,-0.0504203953607639,0.0902058255910808,0.579240738128515
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32857,-0.0126754624341596,0.0167583486784508,-0.0455218258439232,0.020170900975604,0.449450368111916
EPHA2,Ephrin type-A receptor 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32857,-0.0378457472825123,0.0273276021322035,-0.0914078474616311,0.0157163528966065,0.166122590186678
EPHA2,Ephrin type-A receptor 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32857,-0.0361729534763008,0.0409928218819621,-0.116518884364946,0.0441729774123448,0.37757406856166
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20600.Liking for adding salt to foods,34631,-0.0611076033650786,0.0568594465009479,-0.172552118506936,0.0503369117767792,0.282528604085094
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20601.Liking for aniseed,34631,-0.0695779668571189,0.0568664751021867,-0.181036258057405,0.0418803243431669,0.22115707414708
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20602.Liking for apple juice,34631,0.141664662750029,0.0567465761850286,0.0304413734273726,0.252887952072685,0.0125602408702523
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20603.Liking for apples,34631,-0.0604205011286724,0.0582806759400223,-0.174650625971116,0.0538096237137712,0.299892946651997
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20604.Liking for asparagus,34631,-0.26566434429058,0.0583864618230142,-0.380101809463688,-0.151226879117472,5.42413324095923e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20605.Liking for aubergine,34631,-0.335717018591424,0.056766737762809,-0.44697982460653,-0.224454212576318,3.44705496719522e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20606.Liking for avocados,34631,-0.332050735997386,0.0586724422519184,-0.447048722811146,-0.217052749183626,1.56017544951241e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20607.Liking for bacon,34631,-0.214799245329163,0.0569878620843177,-0.326495455014426,-0.1031030356439,0.000164690922094913
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20608.Liking for baked or steamed fish,34631,-0.350626020779692,0.058391050817246,-0.465072480381494,-0.23617956117789,1.98132494351324e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20609.Liking for bananas,34631,0.136646210797453,0.0595500193589316,0.0199281728539467,0.253364248740959,0.0217736955875138
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,34631,-0.389536154489924,0.0566177003828766,-0.500506847240362,-0.278565461739486,6.33265786930199e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20611.Liking for beef steak,34631,-0.354227668310471,0.0571690463645841,-0.466278999185056,-0.242176337435886,6.01044885071049e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20612.Liking for beetroot,34631,-0.0675166657483782,0.0583601575668002,-0.181902574579307,0.0468692430825502,0.247341795400016
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20613.Liking for bell pepper,34631,-0.262526070237182,0.0572034140356749,-0.374644761747105,-0.150407378727259,4.49969762854161e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20614.Liking for bicycling,34631,0.00258469183810734,0.0566717870272178,-0.108492010735239,0.113661394411454,0.963623518216116
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20615.Liking for biscuits,34631,0.382681012323577,0.0571446992598806,0.270677401774211,0.494684622872943,2.24435953376994e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20616.Liking for bitter foods,34631,-0.298345848045903,0.0565562054575478,-0.409196010742697,-0.18749568534911,1.35330275071962e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20617.Liking for bitter or ale,34631,-0.368610043886459,0.0592224646715976,-0.484686074642791,-0.252534013130128,5.03239185888222e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20618.Liking for black olives,34631,-0.363637770649038,0.0576783345863655,-0.476687306438314,-0.250588234859761,3.00966898066742e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20619.Liking for black pepper,34631,-0.220117500334346,0.057715687309125,-0.333240247460231,-0.106994753208461,0.00013764164538323
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20620.Liking for blue cheese,34631,-0.302274580828853,0.0573309955106427,-0.414643332029713,-0.189905829627994,1.37379105703024e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20621.Liking for bolognese sauce,34631,-0.26274035287813,0.0571941997509614,-0.374840984390014,-0.150639721366245,4.40418989139567e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20622.Liking for broad beans,34631,-0.211531079280256,0.0575758961843309,-0.324379835801545,-0.0986823227589678,0.000240054207464289
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20623.Liking for broccoli,34631,-0.167329360502498,0.0595272917096485,-0.284002852253409,-0.0506558687515865,0.00494870406322304
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20624.Liking for brown rice,34631,-0.167618716084587,0.056965201314454,-0.279270510660917,-0.0559669215082575,0.00326334483720428
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20625.Liking for brussel sprouts,34631,-0.10387458040829,0.0578258383097976,-0.217213223495494,0.0094640626789131,0.0724709126691119
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20626.Liking for burgers (meat),34631,-0.224917214542123,0.0569626865129371,-0.33656408010748,-0.113270348976767,7.917231478205e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20627.Liking for burn of spicy foods,34631,-0.358684973109224,0.0569794534825982,-0.470364701935117,-0.247005244283332,3.20105969032684e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20628.Liking for butter on bread,34631,0.0739042927245772,0.0580838538531556,-0.0399400608276078,0.187748646276762,0.203269924165564
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20629.Liking for butternut squash,34631,-0.17526935218986,0.0569318491446737,-0.28685577651342,-0.0636829278662993,0.00208542366904109
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20630.Liking for cabbage,34631,-0.0223643123374577,0.0574555115571996,-0.134977114989569,0.0902484903146535,0.697102530272364
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20631.Liking for cake,34631,0.344613148616267,0.0576506164112914,0.231617940450136,0.457608356782398,2.34036619656462e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20632.Liking for cake icing,34631,0.281670855414358,0.0569705426324185,0.170008591854818,0.393333118973898,7.76987703568173e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20633.Liking for capers,34631,-0.431092878868234,0.0563771802162527,-0.541592152092089,-0.320593605644379,2.25049627234805e-14
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20634.Liking for cauliflower,34631,-0.0817986363702764,0.058497693095603,-0.196454114837658,0.0328568420971054,0.162046755995774
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20635.Liking for cereal or granola bar,34631,0.0911587528111842,0.0569159789007507,-0.0203965658342871,0.202714071456655,0.109266903026391
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20636.Liking for cheesecake,34631,0.132976928079377,0.0573375770643148,0.0205952770333202,0.245358579125434,0.0204042662477886
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20637.Liking for cherries,34631,-0.242320068607295,0.0623575191199084,-0.364540806082316,-0.120099331132275,0.000102564704605769
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20638.Liking for chicken,34631,-0.302692031957844,0.0603166167917891,-0.42091260086975,-0.184471463045937,5.29894710463258e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20639.Liking for chilli pepper,34631,-0.44309239559398,0.0571007701456872,-0.555009905079527,-0.331174886108433,9.3209884568775e-15
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20640.Liking for chips or french fries,34631,0.0667285803723978,0.0576018680173856,-0.0461710809416778,0.179628241686474,0.246709796685116
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20641.Liking for cigarette smoking,34631,-0.106936670374278,0.0944418780318422,-0.292042751316688,0.0781694105681332,0.257534438852421
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20642.Liking for cod,34631,-0.30789188484359,0.0589839553786646,-0.423500437385773,-0.192283332301408,1.82525979998266e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20643.Liking for coffee with sugar,34631,0.150273627934838,0.0647248703158865,0.0234128821157004,0.277134373753976,0.020267170123922
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20644.Liking for coffee without sugar,34631,-0.238125819598313,0.0583002234611504,-0.352394257582168,-0.123857381614458,4.45152173281212e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20645.Liking for coriander,34631,-0.310943552664226,0.0576109705067036,-0.423861054857365,-0.198026050471087,6.91729859751982e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20646.Liking for corn flakes,34631,0.314546108359754,0.0573140705435385,0.202210530094419,0.426881686625089,4.15999270963802e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20647.Liking for cream,34631,0.0570019756786616,0.056763813941261,-0.05425509964621,0.168259051003533,0.315308204615081
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20648.Liking for croissant,34631,0.116947030733871,0.0565338039972204,0.00614077489931901,0.227753286568423,0.0386068509530159
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20649.Liking for cucumber,34631,-0.0989521489495555,0.0577489961391846,-0.212140181382357,0.0142358834832464,0.08665347465291
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20650.Liking for curry,34631,-0.332010199255615,0.0576963224087661,-0.445094991176796,-0.218925407334433,8.94411704798953e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20651.Liking for dairy products,34631,0.0550249629627134,0.0581055915401471,-0.0588619964559748,0.168911922381402,0.343670330848518
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20652.Liking for dark chocolate,34631,-0.18619329582979,0.0573210587131589,-0.298542570907582,-0.073844020751999,0.00116492797002832
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,34631,-0.012566986258426,0.059918735954162,-0.130007708728583,0.104873736211732,0.833879617705274
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20654.Liking for dried fruit,34631,0.0192307890959236,0.0571670491359033,-0.0928166272104469,0.131278205402294,0.736578910044384
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20655.Liking for eggs,34631,-0.204233731415394,0.059278934511308,-0.320420443057558,-0.0880470197732307,0.000572728606552285
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20656.Liking for exercising alone,34631,-0.0694701888715766,0.0570354766848555,-0.181259723173893,0.0423193454307401,0.223245711771985
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20657.Liking for exercising with others,34631,-0.0966981940413889,0.0570379434425186,-0.208492563188725,0.0150961751059476,0.0900432568736177
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,34631,-0.350644083902292,0.0583190905677593,-0.4649495014151,-0.236338666389484,1.8895362772174e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20659.Liking for fatty foods,34631,-0.00559417654783795,0.0565137610624112,-0.116361148230164,0.105172795134488,0.921149856082602
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20660.Liking for fresh tomatoes,34631,-0.15022260968897,0.062416261220758,-0.272558481681656,-0.0278867376962846,0.0161112907791101
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20661.Liking for fried chicken,34631,-0.136034868492376,0.0567955463857441,-0.247354139408435,-0.024715597576318,0.0166307329403047
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20662.Liking for fried or battered fish,34631,-0.050419828404417,0.0572403808848006,-0.162610974938626,0.0617713181297922,0.378423243203799
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20663.Liking for fruit,34631,-0.0358957676295395,0.0660922445380735,-0.165436566924164,0.0936450316650845,0.587061713426951
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20664.Liking for garlic,34631,-0.363129929542223,0.0579320442253345,-0.476676736223879,-0.249583122860568,3.80047369247336e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20665.Liking for gherkins,34631,-0.247404191140443,0.0569295811251517,-0.35898617014574,-0.135822212135145,1.40121322316586e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20666.Liking for globe artichoke,34631,-0.294655372202193,0.0566808314797774,-0.405749801902557,-0.183560942501829,2.04802318303889e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20667.Liking for goat's cheese,34631,-0.323258140947009,0.0567418276799793,-0.434472123199768,-0.212044158694249,1.25323372765249e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20668.Liking for going to a cafe,34631,0.179023155089905,0.0575937732453298,0.0661393595290583,0.291906950650751,0.00188637011250955
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20669.Liking for going to the gym,34631,-0.163779760363241,0.0568896135439336,-0.27528340290935,-0.0522761178171309,0.00399891400303684
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20670.Liking for going to the pub,34631,-0.389252654061843,0.0570136571789276,-0.500999422132541,-0.277505885991145,9.14299118309887e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20671.Liking for grapefruit,34631,-0.0879601201794955,0.0574645576537861,-0.200590653180916,0.0246704128219253,0.125878435359229
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20672.Liking for green olives,34631,-0.398268486167063,0.0577010662717436,-0.51136257605968,-0.285174396274446,5.42296988953521e-12
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20673.Liking for haddock,34631,-0.355090446009193,0.0585055237046631,-0.469761272470332,-0.240419619548053,1.33012909143152e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20674.Liking for ham,34631,-0.222928665291804,0.0567739115546337,-0.334205531938886,-0.111651798644722,8.67223652072959e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20675.Liking for hard cheese,34631,0.0473714451883082,0.0582225892784056,-0.0667448297973669,0.161487720173983,0.415877964213226
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20676.Liking for herring,34631,-0.278866262783197,0.0562646615415097,-0.389144999404556,-0.168587526161838,7.2995440204545e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20677.Liking for honey,34631,0.0374258790065613,0.0568355923275091,-0.0739718819553566,0.148823639968479,0.510235855864485
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,34631,-0.375945540778625,0.0570450137293976,-0.487753767688244,-0.264137313869005,4.60585473881554e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20679.Liking for ice cream,34631,0.166240702871007,0.0571860161616428,0.0541561111941872,0.278325294547827,0.00365681972715389
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20680.Liking for jam,34631,0.288030133040897,0.0571735580647261,0.175969959234033,0.40009030684776,4.78952242327083e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20681.Liking for kiwi fruit,34631,0.0322286717847068,0.0577800336872314,-0.0810201942422667,0.14547753781168,0.577005425968952
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20682.Liking for lager,34631,-0.344457975581087,0.0574320043316671,-0.457024704071154,-0.231891247091019,2.06988932364795e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20683.Liking for lamb,34631,-0.358474553964519,0.0575569265096524,-0.471286129923438,-0.2456629780056,4.90561364576422e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20684.Liking for lemons,34631,-0.223832339597032,0.0572941819674302,-0.336128936253195,-0.111535742940869,9.4163182143757e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20685.Liking for lentils or beans,34631,-0.0628135455289025,0.0576781109944521,-0.175862643078029,0.0502355520202237,0.276163767908817
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20686.Liking for liver,34631,-0.334116377512899,0.0578297520353782,-0.44746269150224,-0.220770063523558,7.80057650282148e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20687.Liking for mackerel,34631,-0.307913047920006,0.057087414848401,-0.419804381022872,-0.19602171481714,7.05645017197125e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20688.Liking for marzipan,34631,0.137040008494423,0.0567564097819271,0.025797445321846,0.248282571667,0.0157730964125587
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20689.Liking for mayonnaise,34631,-0.0498485731113092,0.0573074741673033,-0.162171222479224,0.0624740762566053,0.384406090776024
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20690.Liking for melon,34631,-0.0211203720372468,0.0605385767751791,-0.139775982516598,0.0975352384421043,0.727190673615449
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20691.Liking for milk chocolate,34631,0.197541848008984,0.0576680363434768,0.0845124967757693,0.310571199242198,0.000616094653302126
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20692.Liking for mushrooms,34631,-0.239848558417943,0.0593546588263294,-0.356183689717548,-0.123513427118337,5.36294475317064e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20694.Liking for orange juice,34631,0.113156019353336,0.0569031791918749,0.00162578813726155,0.224686250569411,0.0467753166238511
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20695.Liking for oranges,34631,-0.131639305627228,0.0582223028717704,-0.245755019255898,-0.0175235919985578,0.0237817017054378
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20696.Liking for pasta,34631,-0.00667006940155963,0.0574593332401101,-0.119290362552175,0.105950223749056,0.907588810691187
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20697.Liking for pears,34631,0.092604169199598,0.058801554674824,-0.022646877963057,0.207855216362253,0.11532005375425
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20698.Liking for pizza,34631,0.0248987831933472,0.0568810487406688,-0.0865880723383636,0.136385638725058,0.661588234476159
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20699.Liking for plain yogurt,34631,-0.267570136839615,0.0575284637135588,-0.38032592571819,-0.15481434796104,3.34347004283865e-06
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20700.Liking for plums,34631,0.0207984421129616,0.0588589107094705,-0.0945650228776006,0.136161907103524,0.723825162220184
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20701.Liking for pollock,34631,-0.338503650779857,0.0564254086527184,-0.449097451739185,-0.227909849820529,2.05131564416283e-09
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20702.Liking for pork chop,34631,-0.304252500312645,0.0568920108684427,-0.415760841614793,-0.192744159010497,9.09127747321107e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20703.Liking for porridge,34631,0.0477794052802071,0.058618138423998,-0.067112146030829,0.162670956591243,0.415036495947208
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20704.Liking for potato crisps,34631,0.0813038267194506,0.0575007296028153,-0.0313976033020673,0.194005256740969,0.157403771907946
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20705.Liking for potatoes,34631,0.184365263523188,0.0581069585773623,0.070475624711558,0.298254902334818,0.00151394217729557
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20706.Liking for prawns,34631,-0.486128855799588,0.0586575906261886,-0.601097733426918,-0.371159978172259,1.30165277028287e-16
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20707.Liking for raw carrots,34631,-0.0987306153051918,0.0577927579289861,-0.212004420846005,0.014543190235621,0.087600787481193
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20708.Liking for red meat,34631,-0.351783405500453,0.0570866622942407,-0.463673263597165,-0.239893547403741,7.44276236642907e-10
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20709.Liking for red wine,34631,-0.593147443864196,0.057184793961947,-0.705229640029612,-0.48106524769878,4.41204185051718e-25
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,34631,0.104557154583174,0.0598635523077817,-0.0127754079400779,0.221889717106426,0.080738460709702
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20711.Liking for roast chicken,34631,-0.299367740970223,0.0601456137400297,-0.417253143900681,-0.181482338039765,6.55063980254288e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20712.Liking for salad dressing,34631,-0.104798547495843,0.0568881454756964,-0.216299312628208,0.00670221763652144,0.0654770355418129
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20713.Liking for salad leaves,34631,-0.185659679764205,0.0591607171196719,-0.301614685318762,-0.0697046742096483,0.00170459702073504
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20714.Liking for salami,34631,-0.423780620044114,0.0572890558577752,-0.536067169525354,-0.311494070562875,1.50029105106085e-13
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20715.Liking for salmon,34631,-0.409983727574283,0.0612929740813971,-0.530117956773821,-0.289849498374744,2.36645467218441e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20716.Liking for salty foods,34631,-0.0867463438791001,0.0563170442490539,-0.197127750607246,0.0236350628490455,0.123513161467526
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20717.Liking for salty pretzels,34631,-0.154791858326978,0.0573847821921438,-0.26726603142358,-0.0423176852303766,0.00699906314605004
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20718.Liking for sardines,34631,-0.382245221249873,0.0571992189607612,-0.494355690412965,-0.270134752086781,2.46866417714073e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20719.Liking for sausages (meat),34631,-0.236492205824464,0.0565767726470214,-0.347382680212626,-0.125601731436302,2.93920162703914e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20720.Liking for savoury biscuits,34631,0.0407934195011282,0.0575142047257632,-0.0719344217613676,0.153521260763624,0.478169754102947
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),34631,-0.497598525415436,0.0570385189657945,-0.609394022588393,-0.385803028242479,3.10830943736058e-18
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20722.Liking for skimmed milk,34631,-0.216850965030762,0.0567282043357049,-0.328038245528744,-0.105663684532781,0.000132822989322675
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20723.Liking for smoked fish,34631,-0.324167729745436,0.0570977200573705,-0.436079261057882,-0.21225619843299,1.40490733427128e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20724.Liking for soft cheese,34631,-0.199192182108433,0.0573446211839013,-0.311587639628879,-0.0867967245879864,0.000515666935929187
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20725.Liking for soy sauce,34631,-0.322577060227337,0.0570577365436843,-0.434410223852958,-0.210743896601716,1.61433761400747e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20726.Liking for soya milk,34631,0.000337004662782556,0.0567992338725948,-0.110989493727503,0.111663503053068,0.995266087032552
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20727.Liking for spicy foods,34631,-0.370218967271011,0.0569910893665288,-0.481921502429408,-0.258516432112615,8.62921584944941e-11
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20728.Liking for spinach,34631,-0.227266174396139,0.0582188940312393,-0.341375206697368,-0.11315714209491,9.53645814493334e-05
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20729.Liking for spirits,34631,-0.494018931880282,0.0573287485674606,-0.606383279072505,-0.381654584688059,7.87365759716554e-18
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20730.Liking for strawberries,34631,0.00280096783308568,0.0653304285351021,-0.125246672095714,0.130848607761886,0.965802925684649
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,34631,0.104414620065501,0.0594256015663958,-0.0120595590046349,0.220888799135637,0.0789368887027027
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20732.Liking for sweet foods,34631,0.422464962743313,0.0573312382744603,0.310095735725371,0.534834189761256,1.85493329076067e-13
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20733.Liking for taking the stairs,34631,-0.210827378473416,0.0581626523360529,-0.32482617705208,-0.0968285798947527,0.000290608788461939
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20734.Liking for tea with sugar,34631,0.216021538505639,0.0752939359299131,0.0684454240830094,0.363597652928269,0.00412563772956921
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20735.Liking for tea without sugar,34631,-0.117927019931614,0.0611775537250877,-0.237835025232786,0.0019809853695581,0.0539303389614811
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20736.Liking for tomato ketchup,34631,-4.847552177294e-05,0.0565048220997203,-0.110797926837225,0.110700975793679,0.999315511252921
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20737.Liking for tinned tuna,34631,-0.213172930071362,0.0580985936759588,-0.327046173676241,-0.0992996864664826,0.000244594189514083
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20738.Liking for turnip (white),34631,-0.0439411816483536,0.0567678253424257,-0.155206119319508,0.0673237560228008,0.438918733105209
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20739.Liking for vegetables,34631,-0.143462869495031,0.0657542069943544,-0.272341115203965,-0.0145846237860963,0.0291467269490892
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20740.Liking for vinegar,34631,-0.139937584064261,0.0574370643706262,-0.252514230230688,-0.0273609378978336,0.0148527980566476
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20741.Liking for watching television,34631,0.138645770230109,0.0573085846561713,0.0263209443040131,0.250970596156205,0.0155685008375879
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20742.Liking for whisky,34631,-0.29932654250628,0.0607352564007206,-0.418367645051692,-0.180285439960867,8.42215000332654e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20743.Liking for white bread,34631,0.186547024028651,0.0569940087386361,0.0748387669009245,0.298255281156378,0.00106730318206437
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20744.Liking for white rice,34631,0.0331901505389689,0.0569733900225628,-0.0784776939052542,0.144857994983192,0.560205616601944
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20745.Liking for white wine,34631,-0.532770870412966,0.0572118260791446,-0.644906049528089,-0.420635691297843,1.51042705086732e-20
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,34631,-0.0575994105452784,0.0577597184685373,-0.170808458743612,0.0556096376530548,0.318679242159451
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20747.Liking for whole milk,34631,0.0928775088057214,0.0570158523966073,-0.0188735618916289,0.204628579503072,0.103348872761118
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20748.Liking for wholemeal bread,34631,-0.0225322154350524,0.0600537995168489,-0.140237662488076,0.0951732316179715,0.707519184820467
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X20749.Liking for working up a sweat,34631,-0.0991044814538947,0.0568339179770828,-0.210498960688977,0.0122899977811876,0.0812318733212787
EPHA2,Ephrin type-A receptor 2,Physical measures,X21001.Body mass index (BMI),51139,-0.0966567104044446,0.00803987393831709,-0.112414863323546,-0.0808985574853431,3.3114498244289e-33
EPHA2,Ephrin type-A receptor 2,Physical measures,X21002.Weight,51147,0.0119461179109879,0.00496835288137899,0.00220814626348504,0.0216840895584907,0.0162039294077724
EPHA2,Ephrin type-A receptor 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,33282,0.00351328690965497,0.00351888293537576,-0.00338372364368151,0.0104102974629915,0.318108083359525
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34057,-0.0254676333905338,0.0602070255315235,-0.14347340343232,0.0925381366512523,0.67230398965189
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34073,-0.061114990556377,0.0625928298793152,-0.183796937119835,0.0615669560070807,0.328895970769015
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34074,0.0269710478700616,0.0626946100846508,-0.095910387895854,0.149852483635977,0.667061811183113
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21040.Satisfaction with bowel habits,34027,0.00325218439243917,0.0579796102919875,-0.110387851779856,0.116892220564735,0.955269797090178
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34010,0.0979133773308603,0.0608903255269323,-0.0214316607019269,0.217258415363648,0.107862002280301
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21042.Greatest number of times bowels opened per day,34021,0.031532026938554,0.0627644228500578,-0.0914862418475594,0.154550295724667,0.615406918993328
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21043.Least number of times bowels opened per week,33930,-0.0737299508678179,0.0621899072450589,-0.195622169068133,0.0481622673324975,0.235825295343766
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21044.Average number of times bowels opened per day,33980,0.104537368139976,0.0708799101203265,-0.0343872556958639,0.243461991975816,0.140285440411308
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34077,-0.0970386001876676,0.0630928120539567,-0.220700511813423,0.0266233114380875,0.12407430022251
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34071,-0.0195634798316345,0.0639819148494677,-0.144968032936591,0.105841073273322,0.759789605637908
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,34075,-0.0103089921757142,0.0746784325123189,-0.156678719899859,0.136060735548431,0.890207657798944
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34075,-0.00918428137290329,0.066313889810446,-0.139159505401378,0.120790942655571,0.889850460308503
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34071,0.183225723474311,0.0995608290893318,-0.0119135015407789,0.378364948489402,0.0657492038853576
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34072,-0.0903397709900865,0.0725320139270491,-0.232502518287103,0.0518229763069298,0.212972541131392
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34072,-0.205458051192142,0.182790468501212,-0.563727369454518,0.152811267070234,0.261037444277024
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34076,0.129477232712563,0.0690529884831946,-0.00586662471449861,0.264821090139624,0.0608172482171236
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34075,-0.185353286846735,0.0721376007588832,-0.326742984334146,-0.043963589359324,0.010201207126554
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,33821,0.211644129228683,0.0650426782578501,0.0841604798432973,0.33912777861407,0.00114225143498208
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34072,-0.0848075504661698,0.0652951567879657,-0.212786057770583,0.043170956838243,0.194032138554728
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34074,-0.279224088364567,0.0849834522769835,-0.445791654827455,-0.11265652190168,0.00102119107457119
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34076,-0.102730413693635,0.0639895100363229,-0.228149853364828,0.0226890259775576,0.108432931902201
EPHA2,Ephrin type-A receptor 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34074,0.132180552900211,0.0635802101425846,0.00756334102074509,0.256797764779677,0.0376476892668194
EPHA2,Ephrin type-A receptor 2,Working and living environment,X21100.Water hardness (USGS classification),51004,-0.0138379074856442,0.0347361327300794,-0.0819207276365998,0.0542449126653114,0.690359095519615
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2139.Age first had sexual intercourse,47457,0.00140400523360292,0.00252987490586406,-0.00355454958189063,0.00636256004909648,0.578920425585668
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2149.Lifetime number of sexual partners,45980,-0.118175519895012,0.0394343701729516,-0.195466885433998,-0.0408841543560272,0.00273172405027388
EPHA2,Ephrin type-A receptor 2,Physical activities,X22032.IPAQ activity group,45123,-0.0879663473497374,0.0400642543365691,-0.166492285849413,-0.00944040885006206,0.0281293878952729
EPHA2,Ephrin type-A receptor 2,Physical activities,X22033.Summed days activity,45783,-0.00973292144316404,0.00238075036410707,-0.0143991921568139,-0.00506665072951418,4.36374620148332e-05
EPHA2,Ephrin type-A receptor 2,Physical activities,X22034.Summed minutes activity,45123,-0.00717394048871499,0.00239005041178477,-0.0118584392958131,-0.00248944168161685,0.00268898316363509
EPHA2,Ephrin type-A receptor 2,Physical activities,X22037.MET minutes per week for walking,44119,-0.00531911120563956,0.00241601156188804,-0.0100544938669401,-0.000583728544338999,0.0277045557663449
EPHA2,Ephrin type-A receptor 2,Physical activities,X22038.MET minutes per week for moderate activity,45123,-0.00453447530621223,0.00236191053869121,-0.00916381996204699,9.48693496225384e-05,0.0548926634965464
EPHA2,Ephrin type-A receptor 2,Physical activities,X22039.MET minutes per week for vigorous activity,45123,-0.151776567764618,0.0399391027807638,-0.230057209214915,-0.0734959263143211,0.000144994009437795
EPHA2,Ephrin type-A receptor 2,Physical activities,X22040.Summed MET minutes per week for all activity,44119,-0.00475991180334442,0.00246208871067181,-0.00958560567626116,6.57820695723291e-05,0.0532158020903187
EPHA2,Ephrin type-A receptor 2,Eye measures,X2217.Age started wearing glasses or contact lenses,47490,-0.00317013617388401,0.00230271673469839,-0.00768346097389285,0.00134318862612482,0.168620271537966
EPHA2,Ephrin type-A receptor 2,Working and living environment,X22501.Year ended full time education,31104,-0.0187648367728452,0.010267671605197,-0.0388894731190313,0.00135979957334092,0.0676596439441351
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X22506.Tobacco smoking,31060,-0.0648344585164791,0.150618864773116,-0.360047433471786,0.230378516438828,0.666879629724561
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,49405,-0.192684776014158,0.0856253175904537,-0.360510398491447,-0.0248591535368687,0.0244370075869675
EPHA2,Ephrin type-A receptor 2,Physical measures,X23098.Weight,50734,0.0144176794153387,0.00499220038663124,0.0046329666575415,0.024202392173136,0.00387965650223238
EPHA2,Ephrin type-A receptor 2,Physical measures,X23099.Body fat percentage,50735,-0.0389857282174215,0.00512198568041551,-0.0490248201510359,-0.0289466362838071,2.80127185036435e-14
EPHA2,Ephrin type-A receptor 2,Physical measures,X23100.Whole body fat mass,50726,-0.0232719772576387,0.00491132171082543,-0.0328981678108565,-0.0136457867044208,2.16501345271882e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,X23101.Whole body fat-free mass,50734,0.0246125558835904,0.00410947282969585,0.0165579891373865,0.0326671226297943,2.13581844054871e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23102.Whole body water mass,50734,0.0245077150588831,0.00412324132136266,0.0164261620690123,0.0325892680487539,2.82002360496905e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23104.Body mass index (BMI),50734,-0.0908926225462333,0.00812498547666726,-0.106817594080501,-0.0749676510119655,5.50235625970418e-29
EPHA2,Ephrin type-A receptor 2,Physical measures,X23105.Basal metabolic rate,50732,0.0250090814470742,0.004479588987479,0.0162290870316153,0.033789075862533,2.38879807290435e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,X23106.Impedance of whole body,50728,-0.0181292436606948,0.00335989004503291,-0.0247146281489593,-0.0115438591724303,6.88142977266702e-08
EPHA2,Ephrin type-A receptor 2,Physical measures,X23107.Impedance of leg (right),50731,-0.0376380121627843,0.00273907955940661,-0.0430066080992212,-0.0322694162263473,8.09889733340049e-43
EPHA2,Ephrin type-A receptor 2,Physical measures,X23108.Impedance of leg (left),50730,-0.0373376927521374,0.00271297950758347,-0.042655132587001,-0.0320202529172738,6.02956879889703e-43
EPHA2,Ephrin type-A receptor 2,Physical measures,X23109.Impedance of arm (right),50721,0.00875432155720845,0.00336867140488278,0.0021517256036382,0.0153569175107787,0.00936172289599834
EPHA2,Ephrin type-A receptor 2,Physical measures,X23110.Impedance of arm (left),50729,0.00797379621768352,0.00337940627972943,0.00135015990941384,0.0145974325259532,0.0183055809988705
EPHA2,Ephrin type-A receptor 2,Physical measures,X23111.Leg fat percentage (right),50730,-0.107769429352432,0.00805631898424567,-0.123559814561553,-0.0919790441433104,1.11969967357735e-40
EPHA2,Ephrin type-A receptor 2,Physical measures,X23112.Leg fat mass (right),50729,-0.0656737274354817,0.00927748593239862,-0.083857599862983,-0.0474898550079804,1.49029679573447e-12
EPHA2,Ephrin type-A receptor 2,Physical measures,X23113.Leg fat-free mass (right),50729,0.0475420534015887,0.00416445892595315,0.0393797139067205,0.0557043928964569,4.09017785883132e-30
EPHA2,Ephrin type-A receptor 2,Physical measures,X23114.Leg predicted mass (right),50728,0.0472574306065449,0.0041795540071942,0.0390655047524442,0.0554493564606455,1.42122463033386e-29
EPHA2,Ephrin type-A receptor 2,Physical measures,X23115.Leg fat percentage (left),50725,-0.107437815604633,0.0083205691195757,-0.123746131079001,-0.0911295001302645,5.00758801369015e-38
EPHA2,Ephrin type-A receptor 2,Physical measures,X23116.Leg fat mass (left),50725,-0.0690150210530718,0.00930800269527562,-0.087258706335812,-0.0507713357703316,1.2568675536269e-13
EPHA2,Ephrin type-A receptor 2,Physical measures,X23117.Leg fat-free mass (left),50723,0.0472925502224636,0.00427413275186655,0.0389152500288052,0.0556698504161221,2.14706248477379e-28
EPHA2,Ephrin type-A receptor 2,Physical measures,X23118.Leg predicted mass (left),50722,0.0466560771410727,0.00429124280433502,0.0382452412445761,0.0550669130375694,1.78576368607999e-27
EPHA2,Ephrin type-A receptor 2,Physical measures,X23119.Arm fat percentage (right),50722,-0.0298367083845218,0.00569774721384619,-0.0410042929236604,-0.0186691238453833,1.6483817851798e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X23120.Arm fat mass (right),50718,-0.0315163608771091,0.00513326006344061,-0.0415775506014527,-0.0214551711527655,8.38940955337326e-10
EPHA2,Ephrin type-A receptor 2,Physical measures,X23121.Arm fat-free mass (right),50720,0.00593935993209214,0.0039990959477383,-0.00189886812547493,0.0137775879896592,0.13750930007211
EPHA2,Ephrin type-A receptor 2,Physical measures,X23122.Arm predicted mass (right),50719,0.0058307920128447,0.00399653417634284,-0.00200241497278727,0.0136639989984767,0.144587488789354
EPHA2,Ephrin type-A receptor 2,Physical measures,X23123.Arm fat percentage (left),50716,-0.0332561454649559,0.00638168178537748,-0.0457642417642958,-0.0207480491656161,1.89052045190383e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,X23124.Arm fat mass (left),50715,-0.0321652747635794,0.00526496099713831,-0.0424845983179705,-0.0218459512091883,1.01468986764747e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,X23125.Arm fat-free mass (left),50715,0.00601610382874011,0.00430483398595119,-0.00242137078372423,0.0144535784412044,0.162268207347846
EPHA2,Ephrin type-A receptor 2,Physical measures,X23126.Arm predicted mass (left),50713,0.00698052761672409,0.00431343984369066,-0.00147381447690961,0.0154348697103578,0.10560557957812
EPHA2,Ephrin type-A receptor 2,Physical measures,X23127.Trunk fat percentage,50711,-0.0148103076557884,0.0032419701568634,-0.0211645691632407,-0.00845604614833615,4.93919501204338e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,X23128.Trunk fat mass,50707,-0.00934393711138938,0.00373601941100706,-0.0166665351569632,-0.00202133906581553,0.0123889318821915
EPHA2,Ephrin type-A receptor 2,Physical measures,X23129.Trunk fat-free mass,50702,0.012838997597865,0.00383989564565177,0.00531280213238751,0.0203651930633425,0.000828205549669176
EPHA2,Ephrin type-A receptor 2,Physical measures,X23130.Trunk predicted mass,50699,0.0130508765332429,0.00384589247943823,0.00551292727354396,0.0205888257929418,0.000691179953463228
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23400.Total Cholesterol,39759,-0.0301023219722019,0.0029036105057459,-0.0357933985634638,-0.0244112453809399,4.23297854263794e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,39759,-0.0197661499889742,0.00281955828844275,-0.025292484234322,-0.0142398157436264,2.47622483647785e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",39759,-0.013018188749043,0.00281825859831158,-0.0185419756017337,-0.00749440189635228,3.88301811736684e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23403.VLDL Cholesterol,39759,0.00199374125948593,0.00276604901117756,-0.00342771480242208,0.00741519732139394,0.471049560073931
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,39759,-0.0266156882867774,0.00281777396100828,-0.0321385252503536,-0.0210928513232011,4.03230796567368e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23405.LDL Cholesterol,39759,-0.0251612935565698,0.00281735657843154,-0.0306833124502957,-0.019639274662844,4.70222693524934e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23406.HDL Cholesterol,39759,-0.0432475711390441,0.00322221967981751,-0.0495631217114864,-0.0369320205666018,7.68248212928379e-41
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23407.Total Triglycerides,39759,0.0179616961865655,0.00298831356669611,0.0121046015958412,0.0238187907772899,1.88980259962827e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23408.Triglycerides in VLDL,39759,0.0158071028570503,0.00298744171812176,0.00995171708953167,0.021662488624569,1.23202007372087e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23409.Triglycerides in LDL,39759,0.0175766314599612,0.00298795649707818,0.011720236725688,0.0234330261942345,4.12563108965642e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23410.Triglycerides in HDL,39759,0.0218459360010411,0.00281953580215473,0.0163196458288178,0.0273722261732644,9.91402607335957e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,39759,-0.0279856551964634,0.00295928996369618,-0.0337858635253079,-0.0221854468676189,3.62401561261838e-21
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23412.Phospholipids in VLDL,39759,0.00981017039128681,0.00284642332871082,0.0042311806670136,0.01538916011556,0.000569443888711388
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23413.Phospholipids in LDL,39759,-0.0241387718495549,0.00279834938902741,-0.0296235366520487,-0.0186540070470612,6.96499025439017e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23414.Phospholipids in HDL,39759,-0.0347815773757223,0.00313537080337876,-0.0409269041503446,-0.0286362506010999,1.7362919408532e-28
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23415.Total Esterified Cholesterol,39759,-0.0327853028105672,0.00291044936007316,-0.0384897835563106,-0.0270808220648238,2.55698657312742e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,39759,-0.000561777556430602,0.00274999655264624,-0.00595177079961723,0.00482821568675603,0.838135066755697
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,39759,-0.0233158753048753,0.00281272665076274,-0.0288288195403702,-0.0178029310693803,1.23169738054899e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,39759,-0.0449012074950536,0.00319896376501687,-0.0511711764744866,-0.0386312385156205,1.76677839134201e-44
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23419.Total Free Cholesterol,39759,-0.0228942866716679,0.00288437861714097,-0.0285476687612642,-0.0172409045820716,2.2081260272941e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,39759,0.00547493650657501,0.00281436183500686,-4.12126900384228e-05,0.0109910857031885,0.0517503945146331
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23421.Free Cholesterol in LDL,39759,-0.0293729760574158,0.00283781005501304,-0.0349350837652413,-0.0238108683495902,5.0303573771253e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23422.Free Cholesterol in HDL,39759,-0.0345223361863061,0.00324396338906999,-0.0408805044288833,-0.0281641679437289,2.34844934968607e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,39759,-0.0195446506044492,0.00290019548400437,-0.0252290337530977,-0.0138602674558006,1.65084057756947e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23424.Total Lipids in VLDL,39759,0.0109545541829429,0.00290253762898842,0.00526558043012565,0.0166435279357602,0.000161172962426525
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23425.Total Lipids in LDL,39759,-0.0229730203350495,0.00281373740967774,-0.0284879456580179,-0.0174580950120811,3.47474782524464e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23426.Total Lipids in HDL,39759,-0.0365809070864968,0.00317054933514549,-0.042795183783382,-0.0303666303896116,1.14036982187749e-30
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,39759,-0.0452644034214686,0.00295629708731761,-0.0510587457126111,-0.0394700611303261,1.57744362698204e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23428.Concentration of VLDL Particles,39759,0.00800775722795862,0.00280613499400719,0.00250773263970453,0.0135077818162127,0.00432766464758599
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23429.Concentration of LDL Particles,39759,-0.0127715498641552,0.00279711805283839,-0.0182539012477184,-0.00728919848059197,5.01069823223992e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23430.Concentration of HDL Particles,39759,-0.0453176266568404,0.00296253506944456,-0.0511241953929517,-0.039511057920729,1.95790760893445e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,39759,0.0117965837723471,0.00314968087520035,0.00562320925695437,0.0179699582877397,0.000180819704674887
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,39759,-0.0178943895609062,0.00288630868884699,-0.0235515545910463,-0.0122372245307661,5.80040233261084e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,39759,-0.00696452610455196,0.00340551766974798,-0.013639340737258,-0.000289711471845917,0.0408649024262721
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23434.Phosphoglycerides,39746,-0.0275926413850976,0.00297641047365288,-0.0334264059134572,-0.0217588768567379,2.09652738792697e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,39746,0.0352033882229545,0.00314818054390174,0.0290329543569071,0.0413738220890019,6.4569699809305e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23436.Total Cholines,39746,-0.0292114315695052,0.00298072260559639,-0.0350536478764741,-0.0233692152625362,1.310813895654e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23437.Phosphatidylcholines,39746,-0.0253445397601492,0.00298580697170202,-0.0311967214246851,-0.0194923580956132,2.2864989622138e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23438.Sphingomyelins,39745,-0.0348018810762167,0.00299169246102588,-0.0406655982998275,-0.028938163852606,3.79528977963604e-31
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23439.Apolipoprotein B,39759,-0.0113834318925318,0.00279626129646688,-0.0168641040336069,-0.00590275975145671,4.70576695462631e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23440.Apolipoprotein A1,39759,-0.0376884055497593,0.00307185429553151,-0.043709239969001,-0.0316675711305175,1.93005093182462e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,39759,0.00844032082579279,0.00282215804713842,0.0029088910534015,0.0139717505981841,0.00278751696283551
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23442.Total Fatty Acids,39746,-0.00792554107906864,0.00299720761392054,-0.0138000680023529,-0.00205101415578439,0.00819416245959348
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23443.Degree of Unsaturation,39746,-0.0625100199848978,0.00309165983324841,-0.0685696732580647,-0.0564503667117309,9.90195330937837e-90
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,39746,-0.045565822693159,0.0029047629252606,-0.0512591580266697,-0.0398724873596482,5.01413525264717e-55
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,39746,-0.0148225463408182,0.0028883333826779,-0.0204836797708669,-0.00916141291076951,2.90393658054704e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,39746,-0.0244281184410133,0.00291032427768537,-0.0301323540252766,-0.01872388285675,5.12337625973444e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,39746,0.0134643761189266,0.00307605904952469,0.0074353003818582,0.019493451855995,1.21037887136651e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23448.Saturated Fatty Acids,39746,-0.00925872573896427,0.00306200218062294,-0.0152602500129852,-0.0032572014649433,0.00250077442601703
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23449.Linoleic Acid,39746,-0.00193081664591216,0.00286196639967267,-0.00754027078927058,0.00367863749744627,0.499910351175806
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23450.Docosahexaenoic Acid,39746,-0.0579526289114497,0.00303864951037474,-0.0639083819517842,-0.0519968758711152,3.68140927451216e-80
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,39746,-0.0507509480515902,0.00289354672900403,-0.0564222996404381,-0.0450795964627423,3.33426796349527e-68
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,39746,-0.0074234481766641,0.00327956474775663,-0.0138513950822671,-0.000995501271061103,0.0236159563627589
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,39746,-0.0349528213305158,0.0032807444475255,-0.0413830804476658,-0.0285225622133658,2.06887040040914e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,39746,0.0531300631536056,0.00320465977971694,0.0468489299853604,0.0594111963218508,3.37954404919801e-61
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,39746,-0.0071897472348433,0.00305850434229898,-0.0131844157457493,-0.0011950787239373,0.0187487684952835
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,39746,0.0121892268629083,0.00314418019769474,0.00602663367542661,0.01835182005039,0.00010629978980937
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,39746,-0.0563820957325124,0.00308181135885221,-0.0624224459958628,-0.0503417454691621,5.56276611260558e-74
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,39746,-0.0475659148664104,0.00324951131954867,-0.0539349570527258,-0.041196872680095,3.41084234916218e-48
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,39744,0.0443371733845121,0.00288896619384044,0.0386747996445848,0.0499995471244393,9.16264871186804e-53
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23460.Alanine,39753,0.00754060986765518,0.00279185239282854,0.00206857917771124,0.0130126405575991,0.00692211178735173
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23461.Glutamine,39714,0.013681361497946,0.00282247941579085,0.00814930184299596,0.0192134211528961,1.26394181413471e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23462.Glycine,39741,0.0448048303972995,0.00267396893211925,0.0395638512903457,0.0500458095042532,1.84800505375472e-62
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23463.Histidine,39739,-0.00288685279296798,0.00275298804471648,-0.00828270936061228,0.00250900377467633,0.294367205171703
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),39750,-0.0176631693585277,0.00280565288626511,-0.0231622490156073,-0.0121640897014481,3.14635725077226e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23465.Isoleucine,39756,-0.00851304010760278,0.00275155298033548,-0.0139060839490603,-0.00311999626614525,0.00197897498815009
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23466.Leucine,39757,-0.0155550438435273,0.00280373315202798,-0.0210503608215021,-0.0100597268655524,2.93788006747905e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23467.Valine,39750,-0.0212719449535989,0.0028293498493896,-0.0268174706584026,-0.0157264192487953,5.85601556959821e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23468.Phenylalanine,39756,0.0191984490902919,0.00274363076206282,0.0138209327966488,0.0245759653839351,2.71460103306129e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23469.Tyrosine,39740,-0.00461889213829058,0.00275893020925197,-0.0100263953484244,0.00078861107184328,0.0941195041376819
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23470.Glucose,39727,-0.000257648589630285,0.00291610551008865,-0.00597321538940404,0.00545791821014346,0.929596750804897
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23471.Lactate,39728,0.00448125667289803,0.00273537731444717,-0.000880082863418417,0.00984259620921447,0.101388258471067
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23472.Pyruvate,39716,-0.00228796460787362,0.00282568550600646,-0.00782630819964628,0.00325037898389905,0.418123804911276
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23473.Citrate,39758,0.0377392327672647,0.0027908238759369,0.0322692179704283,0.043209247564101,1.9890793985356e-41
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23474.3-Hydroxybutyrate,39561,-0.00513392021589976,0.00263627076916426,-0.0103010109234617,3.31704916621814e-05,0.0515031833948202
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23475.Acetate,39748,-0.00395402228989691,0.00285583698491571,-0.0095514627803317,0.00164341820053789,0.166213177547304
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23476.Acetoacetate,39759,-0.016038598926023,0.00273213111563149,-0.0213935759126607,-0.0106836219393853,4.43840910453618e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23477.Acetone,39759,-0.0155765927889498,0.00274431363760631,-0.0209554475186582,-0.0101977380592414,1.40419585013578e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23478.Creatinine,39304,0.125269583299223,0.00306980722162789,0.119252761144833,0.131286405453614,0
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23479.Albumin,39757,-0.0480090591731799,0.00281154073420013,-0.0535196790122121,-0.0424984393341476,8.95300503796841e-65
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23480.Glycoprotein Acetyls,39759,0.0248687373523858,0.00302237662290956,0.0189448791714831,0.0307925955332885,2.05215424083994e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,39759,0.0200139327065258,0.00301271479527323,0.0141090117077902,0.0259188537052613,3.17394049731888e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,39759,0.0174773981646402,0.00301272334221122,0.0115724604139062,0.0233823359153742,6.71439261816149e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,39759,0.0190649481562764,0.00297009804287761,0.0132435559922363,0.0248863403203165,1.41244528175881e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,39759,0.0177746281714802,0.00296489242556756,0.0119634390173677,0.0235858173255926,2.08015790701803e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,39759,0.0179246821015014,0.00294662719546278,0.0121492927983944,0.0237000714046085,1.20672600406949e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,39759,0.0174381996114554,0.00297902991562804,0.0115993009768244,0.0232770982460863,4.907375533054e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,39759,0.0159032560756198,0.00303401868708284,0.00995657944893738,0.0218499327023021,1.61263688683889e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,39759,0.0173479950551127,0.00295866546414563,0.0115490107453872,0.0231469793648381,4.6267587749965e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,39759,0.0158086984347366,0.00296526057550692,0.00999678770674305,0.0216206091627302,9.88952486145758e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,39759,0.0167343597624259,0.00294066009106473,0.010970665983939,0.0224980535409128,1.28850617564212e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,39759,0.012086389848644,0.00285900513608495,0.00648273978191751,0.0176900399153705,2.37693145108105e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,39759,0.00882381268527469,0.00280247062482447,0.00333097026061872,0.0143166551099307,0.00164379073003055
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,39759,0.0155905200701694,0.00291890214154701,0.0098694718727373,0.0213115682676016,9.36391414924852e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,39759,0.0162923906923178,0.0029977800659107,0.0104167417631328,0.0221680396215027,5.56913417105705e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,39759,0.0153443326564348,0.00293251180907933,0.0095966095106393,0.0210920558022303,1.69450438321387e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,39759,0.0126277234291418,0.0029258949151442,0.00689296939545918,0.0183624774628244,1.59988135486629e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,39759,0.0168425737700253,0.00291135047897805,0.0111363268312283,0.0225488207088223,7.38667226060063e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,39759,0.0121184061680697,0.00283004398013855,0.00657151996699814,0.0176652923691412,1.8630272823034e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,39759,0.0106652522598671,0.00276337188190417,0.0052490433713349,0.0160814611483993,0.000114082635117015
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,39759,0.0132396223400116,0.00290175693101153,0.007552178755229,0.0189270659247942,5.09110253940107e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,39759,0.00992478836239596,0.00297007979105923,0.00410343197191986,0.0157461447528721,0.000834994515462222
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,39759,-0.00198838982721793,0.002787802059338,-0.00745248186352041,0.00347570220908454,0.475704162156634
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,39759,0.000961369946253631,0.00281565364055386,-0.00455731118923193,0.00648005108173919,0.732778880052898
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,39759,-0.00196312586127443,0.00278028042442735,-0.00741247549315203,0.00348622377060317,0.480143440534785
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,39759,-0.0120200249626354,0.00280028603183268,-0.0175085855850275,-0.00653146434024337,1.77816937225251e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,39759,-0.0168040918186008,0.00284598166044471,-0.0223822158730724,-0.0112259677641292,3.6120997518094e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,39759,-0.00519951670873208,0.00277290082266773,-0.0106344023211608,0.000235368903696673,0.0607954918277451
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,39759,0.00980638850508729,0.0029178016162855,0.00408749733716771,0.0155252796730069,0.000778838447886051
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,39759,0.0131437553070032,0.00280710659364928,0.00764182638345059,0.0186456842305558,2.86088817976963e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,39759,0.00976379187049144,0.0027927436601321,0.00429001429663252,0.0152375694443504,0.000473397544203518
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,39759,0.000855919699195522,0.00276081347365038,-0.00455527470915922,0.00626711410755026,0.756546578249825
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,39759,0.00131678607803265,0.00273076646854273,-0.0040355162003111,0.00666908835637639,0.629668043816828
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,39759,0.00513145266735007,0.00271463326563587,-0.000189228533296249,0.0104521338679964,0.0587376371216827
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,39759,-0.00559537873437317,0.00276563274285407,-0.0110160189103672,-0.000174738558379183,0.0430717195394106
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,39759,0.0209710481944737,0.00289068101800766,0.0153053133991787,0.0266367829897687,4.21830410446782e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,39759,0.00532394475109333,0.00282780575196525,-0.000218554522758569,0.0108664440249452,0.0597583123259757
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,39759,0.00598809349240467,0.00282504049349856,0.000451014125147494,0.0115251728596618,0.0340517290526017
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,39759,0.010895449073895,0.00281833330984609,0.00537151578659662,0.0164193823611933,0.000111128797297994
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,39759,-0.0060119649493446,0.00287390358072672,-0.011644815967569,-0.000379113931120224,0.0364624631975511
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,39759,-0.0103880722042323,0.00289340304483476,-0.0160591421721085,-0.00471700223635621,0.000331380295665179
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,39759,0.00392838231626452,0.0028322923332145,-0.0016229106568359,0.00947967528936495,0.16546272840785
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,39759,0.0254364700759008,0.00287137826325188,0.0198085686799271,0.0310643714718744,8.97743564595608e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23523.Concentration of IDL Particles,39759,-0.0159157157137922,0.00283160969031472,-0.0214656707068091,-0.0103657607207754,1.93469018350008e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23524.Total Lipids in IDL,39759,-0.0239692971874594,0.0029030111531599,-0.0296591990476528,-0.018279395327266,1.61883384998885e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23525.Phospholipids in IDL,39759,-0.0198957523187379,0.00291550734608642,-0.0256101467170673,-0.0141813579204085,9.1791198880365e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23526.Cholesterol in IDL,39759,-0.0288658947021257,0.00290186693932592,-0.0345535539032045,-0.0231782355010469,3.04656151559994e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,39759,-0.029298238622604,0.00289406848033767,-0.0349706128440658,-0.0236258644011421,5.16992973159911e-24
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23528.Free Cholesterol in IDL,39759,-0.0268991105305671,0.00292149857041876,-0.0326252477285879,-0.0211729733325463,3.76957260255558e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23529.Triglycerides in IDL,39759,0.0207133234212462,0.00291857030691883,0.0149929256196852,0.0264337212228071,1.33016451548739e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,39759,-0.0135347613303993,0.00280946493036865,-0.0190413125939218,-0.00802821006687673,1.46717740821067e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23531.Total Lipids in Large LDL,39759,-0.0254613996751611,0.00283342416812673,-0.0310149110446894,-0.0199078883056327,2.85614604799725e-19
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23532.Phospholipids in Large LDL,39759,-0.0273062796202149,0.00281938098631899,-0.0328322663534001,-0.0217802928870297,4.03363755144942e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23533.Cholesterol in Large LDL,39759,-0.0274577575734219,0.0028397474866445,-0.0330236626472451,-0.0218918524995986,4.71775989322271e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,39759,-0.0261954912382183,0.00282890335917151,-0.0317401418221945,-0.0206508406542422,2.31171763460093e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,39759,-0.0302098239941759,0.00286727737283421,-0.0358296876449309,-0.0245899603434208,7.2235835588854e-26
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23536.Triglycerides in Large LDL,39759,0.0161995270913312,0.00296484676060229,0.0103884274405507,0.0220106267421117,4.73150479283488e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,39759,-0.0134148080678868,0.00279130273576094,-0.0188857614299782,-0.00794385470579532,1.55494973535277e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,39759,-0.0193804213193208,0.00279973019220924,-0.0248678924960509,-0.0138929501425907,4.62204408611219e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,39759,-0.0203359178541935,0.00277897988056586,-0.0257827184201026,-0.0148891172882845,2.64656243673949e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,39759,-0.0212598511971784,0.00279818246273316,-0.0267442888241354,-0.0157754135702215,3.18763460879701e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,39759,-0.0184301804232674,0.00280917766669766,-0.0239361686499948,-0.01292419219654,5.52736153349082e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,39759,-0.0278398380562391,0.00279520559372523,-0.0333184410199405,-0.0223612350925376,2.68898903614934e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,39759,0.018205537427379,0.00300715286836594,0.0123115178053818,0.0240995570493763,1.44522825170677e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,39759,-0.00602239096708007,0.00278452691467593,-0.0114800637198449,-0.000564718214315253,0.0305715522525177
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23545.Total Lipids in Small LDL,39759,-0.0160023416100652,0.00280583872478088,-0.0215017855106357,-0.0105028977094947,1.19730210849861e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23546.Phospholipids in Small LDL,39759,-0.0159546828495347,0.00279095964766295,-0.0214249637589541,-0.0104844019401153,1.10729764946658e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23547.Cholesterol in Small LDL,39759,-0.0187774759945141,0.00279691196760277,-0.0242594234510155,-0.0132955285380126,1.96498111097529e-11
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,39759,-0.0154762798130398,0.00281608214660892,-0.0209958008203932,-0.00995675880568628,3.9543153961179e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,39759,-0.0254550359502594,0.00277771528407255,-0.0308993579070416,-0.0200107139934772,5.62328334968073e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23550.Triglycerides in Small LDL,39759,0.0216184367401633,0.00302498138970317,0.0156894732163451,0.0275474002639815,9.29465119916477e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,39759,-0.00604169992325372,0.00322696183066736,-0.0123665451113617,0.000283145264854302,0.0611901911362086
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,39759,-0.00799411672882158,0.00324866492788967,-0.0143614999874853,-0.00162673347015782,0.0138760746303191
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,39759,-0.0053815863051383,0.00325140742202179,-0.011754344852301,0.000991172242024396,0.0979133705580455
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,39759,-0.0138811052518655,0.00322722549094417,-0.0202064672141161,-0.00755574328961497,1.70889496001218e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,39759,-0.0170788115066381,0.00327818198754865,-0.0235040482022334,-0.0106535748110427,1.91453356851608e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,39759,-0.00235904397936815,0.00301051852206423,-0.00825966028261405,0.00354157232387774,0.433286655364766
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,39759,0.0285459696653401,0.00291766596515105,0.0228273443736441,0.0342645949570362,1.53811600562587e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,39759,-0.0240066464961048,0.00341518876713306,-0.0307004164796856,-0.017312876512524,2.16225528836952e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23559.Total Lipids in Large HDL,39759,-0.0251710417885932,0.00339745838244651,-0.0318300602181883,-0.018512023358998,1.3411208825342e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23560.Phospholipids in Large HDL,39759,-0.0255426948221199,0.00335405854137603,-0.0321166495632169,-0.0189687400810229,2.78077080207591e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23561.Cholesterol in Large HDL,39759,-0.0275836988453109,0.00339565512600371,-0.0342391828922781,-0.0209282147983436,4.88325097236882e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,39759,-0.028314198691285,0.00338669152588704,-0.0349521140820236,-0.0216762833005464,6.78173904484996e-17
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,39759,-0.0241961080944144,0.00339130707132151,-0.0308430699542046,-0.0175491462346242,1.01316456480633e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23564.Triglycerides in Large HDL,39759,0.0234510985245915,0.00288768652617988,0.0177912329332789,0.029110964115904,4.97080091818598e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,39759,-0.0391387474334413,0.00304582425955397,-0.0451085629821671,-0.0331689318847155,1.34605031315065e-37
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,39759,-0.0384491713473956,0.00302047955540459,-0.0443693112759886,-0.0325290314188026,6.23984347672011e-37
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,39759,-0.0364121014003673,0.00300452671573539,-0.0423009737632087,-0.030523229037526,1.19341215644471e-33
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,39759,-0.0446138527803789,0.00304990800182348,-0.050591672463953,-0.0386360330968049,3.93667677362047e-48
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,39759,-0.045402802165077,0.00303359045327261,-0.0513486394534914,-0.0394569648766627,2.7488740715875e-50
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,39759,-0.0397853588448881,0.00309423291530239,-0.0458500553588808,-0.0337206623308954,1.21607364164012e-37
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,39759,0.0164916851169736,0.00279578574854369,0.0110119450498279,0.0219714251841192,3.73952920697502e-09
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,39759,-0.0417655633413056,0.002736022762202,-0.0471281679552215,-0.0364029587273897,3.16832971232673e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23573.Total Lipids in Small HDL,39759,-0.035802341772006,0.00277430629449403,-0.0412399821092143,-0.0303647014347977,6.65182727204494e-38
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23574.Phospholipids in Small HDL,39759,-0.0345133736694415,0.00280595639752537,-0.0400130482085912,-0.0290136991302918,1.31890493473919e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23575.Cholesterol in Small HDL,39759,-0.0452032488031025,0.00273758369820909,-0.0505689128515923,-0.0398375847546127,1.00561772638647e-60
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,39759,-0.0466595213602822,0.00270390600102038,-0.0519591771222822,-0.0413598655982823,4.22930492261538e-66
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,39759,-0.0329589652038089,0.00285530091953735,-0.0385553550061021,-0.0273625754015157,1.07204772895245e-30
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23578.Triglycerides in Small HDL,39759,0.0211884521768015,0.00288151153672222,0.0155406895648259,0.026836214788777,2.03249792329417e-13
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38907,0.0123366109821842,0.00262823928062925,0.0071852619921509,0.0174879599722176,2.70546112963056e-06
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38907,-0.00377660594689162,0.00275660553759024,-0.0091795528005685,0.00162634090678526,0.17070179785261
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38907,-0.00173348312846138,0.00268825196532535,-0.00700245698049906,0.0035354907235763,0.51904334536449
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38907,-0.00726888757494443,0.00280523776697419,-0.0127671535982138,-0.00177062155167501,0.00957424109945928
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,38907,-0.00120604468777973,0.00267003870125241,-0.00643932054223445,0.00402723116667498,0.651495077677828
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39531,0.0110646635752854,0.00258663350121589,0.00599486191290229,0.0161344652376686,1.90056492467683e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39531,-0.0166168808182041,0.00293459013728708,-0.0223686774872868,-0.0108650841491214,1.51974626887505e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39531,-0.0189864833864121,0.00293881479356806,-0.0247465603818055,-0.0132264063910187,1.0749176993614e-10
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39531,-0.00501911358767851,0.00278239028714307,-0.0104725985504789,0.000434371375121903,0.0712692021992646
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39531,0.0108436134060129,0.00281776051815572,0.00532080279042773,0.0163664240215981,0.00011942624638793
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,39754,0.0307992383989775,0.00275004283947573,0.025409154433605,0.0361893223643499,5.31347123401855e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,39754,-0.00224130276761038,0.00271897162150485,-0.00757048714575988,0.00308788161053913,0.409770589088464
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,39754,-0.00524590580845087,0.00285438688206321,-0.0108405040972948,0.000348692480393029,0.0661053901891829
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,39754,0.00619437292188249,0.00261677611340696,0.00106549173960486,0.0113232541041601,0.0179367161965597
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,39754,-0.0104478762710367,0.00256949587505491,-0.0154840881861444,-0.00541166435592911,4.80417274985376e-05
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,39759,-0.0149861961901962,0.00287436849813459,-0.02061995844654,-0.00935243393385244,1.87483918644197e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,39759,-0.0257835797269831,0.00299752666744648,-0.0316587319951782,-0.019908427458788,8.61325124536763e-18
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,39759,-0.0274925636653074,0.00301900017930267,-0.0334098040167406,-0.0215753233138741,9.540264780002e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,39759,-0.0205810995094298,0.00293482431594249,-0.0263333551686771,-0.0148288438501825,2.43513238167341e-12
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,39759,0.0235766012025492,0.00297737423029179,0.0177409477111773,0.0294122546939211,2.56629644859196e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,39759,-0.0358835160244155,0.00291221699403105,-0.0415914613327164,-0.0301755707161147,1.01087298694698e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,39759,-0.0221176136539334,0.00285828253336562,-0.02771984741933,-0.0165153798885368,1.07208762458826e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,39759,-0.00982011982341965,0.00278213664876954,-0.015273107655008,-0.00436713199183135,0.000417245374791775
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,39759,-0.0355803351166527,0.00292217784949492,-0.0413078037016628,-0.0298528665316427,5.99195996998618e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,39759,0.0268158758665695,0.00287932622077054,0.0211723964738592,0.0324593552592798,1.40522213313039e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,39759,0.0455746845002646,0.00290683637109576,0.0398772852129169,0.0512720837876123,5.68360058570865e-55
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,39759,-0.0390658136310276,0.00303067149873695,-0.045005929768552,-0.0331256974935031,8.04537916324515e-38
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,39759,-0.0413230620833206,0.00304733640613183,-0.047295841439339,-0.0353502827273022,1.19655998653802e-41
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,39759,-0.0157650099615438,0.00297867469063112,-0.0216032123551808,-0.00992680756790679,1.22235973897758e-07
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,39759,0.0332520995882631,0.00303123521341629,0.0273108785699671,0.039193320606559,6.78028586211158e-28
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,39759,0.0304176554298481,0.00272936435179286,0.0250681013003342,0.0357672095593621,9.81551027415862e-29
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,39759,-0.0442747944563627,0.00287338997630628,-0.049906638809923,-0.0386429501028023,3.59388039191064e-53
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,39759,-0.0423709223787558,0.00286490087215537,-0.0479861280881803,-0.0367557166693312,3.73024391808227e-49
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,39759,-0.0233370048312807,0.00297814807765054,-0.0291741750634758,-0.0174998345990857,4.95258510385343e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,39759,0.0442325531105327,0.00297461274367489,0.0384023121329299,0.0500627940881355,1.14612563858957e-49
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,39759,-0.00965744444063691,0.0027325688326723,-0.0150132793526746,-0.0043016095285992,0.000410217871358195
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,39759,-0.0423337428787105,0.00297987243291755,-0.0481742928472289,-0.0364931929101921,1.6237860123815e-45
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,39759,-0.0228097949278082,0.00275814598057933,-0.0282157610497436,-0.0174038288058727,1.44913461828173e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,39759,-0.0296522855720013,0.00299213652613737,-0.0355168731632305,-0.023787697980772,4.41701738956542e-23
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,39759,0.0454100978532156,0.00296455378931019,0.0395995724261676,0.0512206232802635,1.42949909376012e-52
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,39759,-0.00470503477235238,0.00269318555413165,-0.00998367845845042,0.000573608913745658,0.0806548417110408
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,39759,-0.0340730265824106,0.00276736349418746,-0.039497059031018,-0.0286489941338032,1.13266515548741e-34
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,39759,-0.00412506055071068,0.00280763654953791,-0.00962802818780498,0.00137790708638363,0.141791285167928
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,39759,-0.0315008064332989,0.00304261121099041,-0.0374643244068401,-0.0255372884597577,4.89466687064725e-25
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,39759,0.0429806139152199,0.00286713466967699,0.037361029962653,0.0486001978677868,1.92286814043184e-50
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,39759,0.00453570720675893,0.00275922408042887,-0.000872371990881652,0.00994378640439951,0.100230969264193
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,39759,-0.0319895932789772,0.00278425525210859,-0.03744673357311,-0.0265324529848443,1.986340141783e-30
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,39759,-0.00475990284222055,0.00278395294590053,-0.0102164506161856,0.000696644931744482,0.0873297685371972
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,39759,-0.0349789841798926,0.00297374476791578,-0.0408075239250075,-0.0291504444347777,8.33727543009861e-32
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,39759,0.0391969474577296,0.00293891934526165,0.0334366655410167,0.0449572293744424,2.36237763817251e-40
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,39757,0.00530284353238901,0.00317154993381712,-0.000913394337892539,0.0115190814026706,0.0945440144834748
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,39757,-0.0245225438092268,0.00316208658261491,-0.030720233511152,-0.0183248541073016,9.37571254047338e-15
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,39757,-0.0454681850509707,0.00315013108146234,-0.0516424419706369,-0.0392939281313045,6.45111069768125e-47
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,39757,0.0180220280784571,0.00336025493673747,0.0114359284024517,0.0246081277544626,8.29060988103934e-08
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,39757,0.0305814798454307,0.00315927207056914,0.0243893065871151,0.0367736531037462,4.24666331460735e-22
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,39759,-0.00202571201715029,0.00329243085695335,-0.00847887649677886,0.00442745246247829,0.538389968260725
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,39759,-0.024580855724403,0.00327392609600419,-0.0309977508725712,-0.0181639605762347,6.33107769623677e-14
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,39759,-0.0272390347240705,0.00330743434421635,-0.0337216060387346,-0.0207564634094065,1.92821741996178e-16
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,39759,-0.00752192911039199,0.00317245629280393,-0.0137399434442877,-0.00130391477649629,0.0177518064997851
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,39759,0.0445718818866101,0.00316703966644164,0.0383644841403845,0.0507792796328357,1.04727789022843e-44
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,39759,0.028161679646296,0.00309342778690153,0.022098561183969,0.034224798108623,9.78814813249096e-20
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,39759,-0.038112187217138,0.00301304010306256,-0.0440177458191406,-0.0322066286151353,1.72341867420701e-36
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,39759,-0.035732226350791,0.00299840572475284,-0.0416091015713066,-0.0298553511302754,1.34404036815546e-32
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,39759,-0.0326111721904904,0.00323866002706821,-0.0389589458435441,-0.0262633985374367,8.95095603085116e-24
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,39759,0.040848387180688,0.00293384088410628,0.0350980590478397,0.0465987153135363,8.47211015498465e-44
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,39759,0.00747432360892715,0.00288712775336128,0.00181555321233903,0.0131330940055153,0.00963897696889645
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,39759,-0.0340157454861326,0.00288019195050563,-0.0396609217091236,-0.0283705692631415,4.76091230146208e-32
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,39759,-0.0366673791925147,0.00288718237582714,-0.0423262566491359,-0.0310085017358935,9.05735473171272e-37
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,39759,0.00681241083744768,0.00294446001235365,0.00104126921323452,0.0125835524616608,0.0207008375437589
EPHA2,Ephrin type-A receptor 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,39759,0.0435838499987497,0.00292770563209631,0.0378455469598409,0.0493221530376585,8.96548723864967e-50
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,50856,-0.00459303400337196,0.00236306482371748,-0.00922464105785821,3.85730511142978e-05,0.0519450619682932
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,50856,-0.00278224259226978,0.00231531370908909,-0.00732025746208439,0.00175577227754484,0.229502259001216
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,49047,-0.00110069318457797,0.00221784019803093,-0.00544765997271859,0.00324627360356266,0.619693850926033
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,49047,-0.0031037886896132,0.00240939951888613,-0.00782621174663002,0.00161863436740362,0.197688437629959
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,49047,-0.00676667885942051,0.00236595733116659,-0.011403955228507,-0.002129402490334,0.00423974471217215
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,49047,-0.000343786225449818,0.00217012432562287,-0.00459722990367064,0.003909657452771,0.87412892396585
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24009.Traffic intensity on the nearest road,50856,-0.106730546303478,0.0772756592975828,-0.25819083852674,0.0447297459197846,0.167239483553056
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24010.Inverse distance to the nearest road,50856,0.00343486417736015,0.0020656149634353,-0.000613741150973028,0.00748346950569333,0.0963488733511956
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24011.Traffic intensity on the nearest major road,50856,0.00105061588682035,0.0020716783465398,-0.00300987367239766,0.00511110544603836,0.612065929493669
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24012.Inverse distance to the nearest major road,50856,-0.00221115496123749,0.00210423083888849,-0.00633544740545893,0.00191313748298395,0.293353699196853
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24013.Total traffic load on major roads,50856,-0.0381626408452202,0.0530349938122288,-0.142111228717189,0.0657859470267483,0.471793250395181
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24015.Sum of road length of major roads within 100m,50856,-0.0868036837728791,0.0519977992535538,-0.188719370309845,0.0151120027640865,0.0950554823125933
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,50856,-0.00673460362866458,0.00234793830264902,-0.0113365627018567,-0.00213264455547251,0.00413004195117498
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,50856,-0.00718706890831036,0.00234244222472066,-0.0117782556687628,-0.00259588214785788,0.0021557431972227
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,50856,-0.00695448573670893,0.00232049726990443,-0.0115026603857216,-0.00240631108769624,0.0027292130492624
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,50792,-0.00417441074945883,0.00229006606547844,-0.00866294023779658,0.000314118738878912,0.0683398364068807
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24020.Average daytime sound level of noise pollution,50856,-0.00126175797276327,0.00208176290072269,-0.00534201325817974,0.0028184973126532,0.544453089677103
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24021.Average evening sound level of noise pollution,50856,-0.00125818915170027,0.00208156537609522,-0.0053380572888469,0.00282167898544636,0.545553859420066
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24022.Average night-time sound level of noise pollution,50856,-0.00126275102712499,0.00208172956695058,-0.00534294097834812,0.00281743892409814,0.544129946985868
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,50856,-0.00128074961230082,0.00208171169851073,-0.00536090454138185,0.00279940531678021,0.538402391814124
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,50856,-0.00127311905417459,0.00208168846189025,-0.00535322843947947,0.00280699033113029,0.540820931461276
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",47998,0.00640163064678215,0.00241657731365384,0.00166513911202061,0.0111381221815437,0.00807726010841279
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",47998,-0.00175931442493887,0.00220208549703821,-0.00607540199913375,0.00255677314925602,0.424338466108306
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24502.Water percentage, buffer 1000m",47998,-0.00177561497451864,0.00216195297299596,-0.00601304280159072,0.00246181285255345,0.41148293346828
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",47998,0.0048513451042043,0.00227692375094675,0.000388574552348681,0.00931411565605992,0.0331276851891839
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",47998,-0.00101488720801782,0.0022187323999296,-0.00536360271187984,0.00333382829584421,0.647375150155325
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24505.Water percentage, buffer 300m",47998,-0.00039825266534384,0.00217249930535966,-0.00465635130384877,0.00385984597316109,0.85455209896498
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51004,0.00408382427414697,0.00230802461876746,-0.000439903978637258,0.0086075525269312,0.076838223541878
EPHA2,Ephrin type-A receptor 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51004,0.00040267931634993,0.00217639059082053,-0.0038630462416583,0.00466840487435816,0.85321348992043
EPHA2,Ephrin type-A receptor 2,Working and living environment,X24508.Distance (Euclidean) to coast,51004,0.00100102230374079,0.0020834774985983,-0.00308259359351187,0.00508463820099345,0.630906104342734
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,35250,0.0581848669115538,0.0563250968857094,-0.0522123229844366,0.168582056807544,0.301618380304785
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2704.Years since last cervical smear test,44807,0.0144770800988062,0.0409793578127417,-0.0658424612141675,0.0947966214117799,0.723884161577453
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2714.Age when periods started (menarche),50373,0.0808458467014242,0.0349670166061945,0.0123104941532829,0.149381199249565,0.0207821646843354
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2734.Number of live births,51172,-0.0734353021848039,0.0335433608096945,-0.139180289371805,-0.00769031499780272,0.0285862148090216
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2744.Birth weight of first child,45647,-0.203693936859566,0.0370192223090017,-0.276251612585209,-0.131136261133923,3.79030068693763e-08
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2754.Age at first live birth,42492,-0.015389713944257,0.00262494622578363,-0.0205346085467929,-0.010244819341721,4.628749935027e-09
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2764.Age at last live birth,42445,-0.0125240151728573,0.00253572593350299,-0.0174940380025232,-0.00755399234319145,7.92180012175044e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2794.Age started oral contraceptive pill,44945,0.00641000242743692,0.00280296925256264,0.000916182692414148,0.0119038221624597,0.0222140575548651
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2804.Age when last used oral contraceptive pill,43040,-0.00411439724614695,0.00242935652074392,-0.00887593602680503,0.000647141534511133,0.0903550167493939
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2867.Age started smoking in former smokers,29877,-0.00801099937680895,0.00495631433258576,-0.017725375468677,0.00170337671505914,0.106082879892233
EPHA2,Ephrin type-A receptor 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",35151,-0.0332896061230362,0.0668637839556623,-0.164342622676134,0.0977634104300619,0.618584495559413
EPHA2,Ephrin type-A receptor 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,35144,0.037228166969717,0.0724111578689179,-0.104697702453362,0.179154036392796,0.607177346844911
EPHA2,Ephrin type-A receptor 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,35181,0.130327815123251,0.0787346213756498,-0.0239920427730223,0.284647673019525,0.0978970409770763
EPHA2,Ephrin type-A receptor 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",35136,0.127013162525215,0.0757092294197547,-0.0213769271375045,0.275403252187934,0.0934458005427355
EPHA2,Ephrin type-A receptor 2,Mental health,X28739.Difficulty with standing for long periods,35193,0.412647269753425,0.0666313208114139,0.282049880963054,0.543244658543796,6.11920728332454e-10
EPHA2,Ephrin type-A receptor 2,Mental health,X28740.Difficulty with taking care of household responsibilities,35221,0.404539188730556,0.0714700467010964,0.264457897196407,0.544620480264705,1.55007921608646e-08
EPHA2,Ephrin type-A receptor 2,Mental health,X28741.Difficulty learning a new task,35118,0.149992621439272,0.0796719160294147,-0.00616433397838059,0.306149576856925,0.059777930853395
EPHA2,Ephrin type-A receptor 2,Mental health,X28742.Difficulty with joining in community activities,34844,0.344759881438604,0.0847333597049699,0.178682496416863,0.510837266460345,4.76131048821581e-05
EPHA2,Ephrin type-A receptor 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,35146,0.185922108909144,0.0704980904394481,0.0477458516478259,0.324098366170462,0.00836985652624249
EPHA2,Ephrin type-A receptor 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35215,0.442519774011433,0.103029825798356,0.240581315446655,0.644458232576211,1.7617511458797e-05
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29850,0.210268455675624,0.0751623480110848,0.0629502535738981,0.35758665777735,0.00516784566533779
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2897.Age stopped smoking,29886,0.0143483275719484,0.0050984080262152,0.00435544784056665,0.0243412073033302,0.00490630033674498
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34126,0.000357303793191647,0.0063797241368244,-0.0121469555149842,0.0128615631013675,0.955338063683999
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34126,0.000377774326036802,0.00680003777864296,-0.0129502997201034,0.013705848372177,0.955697668836986
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34126,-0.00023596820265755,0.0225422344939004,-0.0444187478107024,0.0439468114053873,0.991648251119333
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34126,-0.000396376156185123,0.0238297101544493,-0.0471026080589058,0.0463098557465355,0.986729185713334
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34126,0.0321870727973412,0.024984830267095,-0.016783194526165,0.0811573401208473,0.197684676384102
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34126,-0.0257173058491865,0.0206730493582203,-0.0662364825912982,0.0148018708929253,0.21352912641967
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34126,-0.00622210851230307,0.00961121625325526,-0.0250600923686834,0.0126158753440773,0.517401442968196
EPHA2,Ephrin type-A receptor 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34126,0.0066944973651621,0.0170829800426426,-0.0267881435184174,0.0401771382487416,0.695154685165111
EPHA2,Ephrin type-A receptor 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34059,-0.0265069742609354,0.0805400729217863,-0.184365517187637,0.131351568665766,0.742075678369436
EPHA2,Ephrin type-A receptor 2,Mental health,X29003.Recent feelings of depression,34044,0.0306409814249274,0.0768595274111742,-0.120003692300974,0.181285655150829,0.690151065341913
EPHA2,Ephrin type-A receptor 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34063,0.0224479829573261,0.0629640042643794,-0.100961465400858,0.14585743131551,0.7214583370411
EPHA2,Ephrin type-A receptor 2,Mental health,X29005.Recent feelings of tiredness or low energy,34070,0.144457373300512,0.0640463329353085,0.0189265607473073,0.269988185853717,0.0241234940065087
EPHA2,Ephrin type-A receptor 2,Mental health,X29006.Recent poor appetite or overeating,34077,0.155720402683181,0.0825801798517506,-0.00613674982625004,0.317577555192612,0.0593671890248652
EPHA2,Ephrin type-A receptor 2,Mental health,X29007.Recent feelings of inadequacy,34031,0.184423848269948,0.0828143893279776,0.0221076451871115,0.346740051352784,0.0259734963859204
EPHA2,Ephrin type-A receptor 2,Mental health,X29008.Recent trouble concentrating on things,34078,0.0306742318520872,0.0840925177104874,-0.134147102860468,0.195495566564642,0.715292854176827
EPHA2,Ephrin type-A receptor 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34064,0.248429341254316,0.146463026568045,-0.0386381908190515,0.535496873327683,0.0898820071269963
EPHA2,Ephrin type-A receptor 2,Mental health,X29010.Recent thoughts of suicide or self-harm,33999,0.326381358319805,0.165385606969415,0.00222556865975104,0.650537147979859,0.048472335355369
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#0.Substances taken for depression_None of options listed,32799,-0.00820265116104093,0.0134515005598761,-0.0345675922583981,0.0181622899363162,0.542014539364808
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32799,-0.0681459869993299,0.0271109525440051,-0.12128345398558,-0.01500852001308,0.0119693909876424
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32799,-0.0127044361300819,0.0126479614209968,-0.0374944405152357,0.0120855682550719,0.315183591004738
EPHA2,Ephrin type-A receptor 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32799,0.0474144010704443,0.0357836988431528,-0.0227216486621351,0.117550450803024,0.185198151702251
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32799,-0.0227063044884603,0.0230969777456827,-0.0679763808699983,0.0225637718930778,0.325593841599631
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32799,0.0345968689702918,0.0239865589433648,-0.0124167865587032,0.0816105244992868,0.14924287814677
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32799,0.0215695933798957,0.0277800376075979,-0.0328792803309961,0.0760184670907875,0.437509939524672
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32799,0.0182025218256406,0.0323552847983467,-0.045213836379119,0.0816188800304001,0.573734218404105
EPHA2,Ephrin type-A receptor 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32799,0.0223844922833071,0.0246384391834825,-0.0259068485163187,0.0706758330829329,0.363630263729845
EPHA2,Ephrin type-A receptor 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32799,-0.0208656363612557,0.0135552892955097,-0.0474340033804547,0.00570273065794331,0.12376934775192
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32799,-0.000148115713287448,0.020396042481389,-0.0401243589768098,0.0398281275502349,0.994206000373689
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32799,-0.0759809863877428,0.0316667314156532,-0.138047779962423,-0.0139141928130626,0.0164439897578184
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32799,-0.0625840402318517,0.0424758896065544,-0.145836783860698,0.020668703396995,0.140680509415932
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32799,-0.0417884121257438,0.0274992034828665,-0.0956868509521622,0.0121100267006745,0.128643720524362
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32799,-0.0343996730305935,0.0476145723456986,-0.127724234828163,0.0589248887669758,0.470031315921587
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32799,-0.0249384819000604,0.0450051413687536,-0.113148558982818,0.0632715951826966,0.579508025651085
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32799,-0.0391378565099406,0.0236844948665141,-0.0855594664483081,0.00728375342842699,0.0984769086833518
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32799,-0.0457316947041799,0.0233121242336156,-0.0914234582020664,-3.99312062933435e-05,0.0498291049886824
EPHA2,Ephrin type-A receptor 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32799,-0.0436680718576212,0.0316785074675757,-0.10575794649407,0.0184218027788271,0.168093223078175
EPHA2,Ephrin type-A receptor 2,Mental health,X29058.Recent feelings or nervousness or anxiety,33926,0.0552723350030714,0.0710704863053881,-0.0840258181554893,0.194570488161632,0.43675853103335
EPHA2,Ephrin type-A receptor 2,Mental health,X29059.Recent inability to stop or control worrying,33939,0.060253431938697,0.072863351127912,-0.0825587362720104,0.203065600149405,0.408293332131175
EPHA2,Ephrin type-A receptor 2,Mental health,X29060.Recent worrying too much about different things,33929,0.0255385995184693,0.0684888405999554,-0.108699528057443,0.159776727094382,0.709240875701521
EPHA2,Ephrin type-A receptor 2,Mental health,X29061.Recent trouble relaxing,33936,0.11186045914425,0.0723540716737511,-0.0299535213363026,0.253674439624802,0.1221343877814
EPHA2,Ephrin type-A receptor 2,Mental health,X29062.Recent restlessness,33947,0.150376787297166,0.104171998185842,-0.0538003291470844,0.354553903741417,0.148900489631286
EPHA2,Ephrin type-A receptor 2,Mental health,X29063.Recent easy annoyance or irritability,33912,0.0733876087383235,0.0758091969271192,-0.0751984172388301,0.221973634715477,0.333040755654903
EPHA2,Ephrin type-A receptor 2,Mental health,X29064.Recent feelings of foreboding,33902,0.08906014914229,0.0821087766190869,-0.0718730530311204,0.2499933513157,0.27809971170203
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32799,-0.0165064549571742,0.0132606079205877,-0.042497246481526,0.00948433656717763,0.213249921962552
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32799,-0.0112504617531595,0.0230708874993609,-0.0564694012519069,0.033968477745588,0.625812316676527
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32799,-0.04509194148253,0.0289589657518406,-0.101851514356138,0.0116676313910776,0.119485182341553
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32799,-0.035435310324547,0.0318111486653427,-0.0977851617086187,0.0269145410595246,0.26534240530101
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,32799,0.00404121591735365,0.0218424659884679,-0.0387700174200433,0.0468524492547506,0.853220613772927
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32799,-0.0317132200491294,0.0214678841250076,-0.0737902729341444,0.0103638328358855,0.139649006039185
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32799,-0.00693907481540557,0.0221630535160581,-0.0503786597068795,0.0365005100760684,0.754218587085814
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32799,-0.00993098567177276,0.0198808024469803,-0.0488973584678541,0.0290353871243086,0.61742175956753
EPHA2,Ephrin type-A receptor 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32799,-0.0307901360545596,0.0270479625767837,-0.0838041427050557,0.0222238705959364,0.255005678954358
EPHA2,Ephrin type-A receptor 2,Mental health,X29076.Felt loved as a child,33902,-0.131148674594508,0.0669349259982371,-0.262341129551053,4.37803620362276e-05,0.0501016541728699
EPHA2,Ephrin type-A receptor 2,Mental health,X29077.Physically abused by family as a child,33916,0.0153820359165753,0.0944961448878255,-0.169830408063563,0.200594479896713,0.870695520259732
EPHA2,Ephrin type-A receptor 2,Mental health,X29078.Felt hated by family member as a child,33896,0.238088518499672,0.0872685449608396,0.0670421703764268,0.409134866622918,0.00637933153199351
EPHA2,Ephrin type-A receptor 2,Mental health,X29079.Sexually molested as a child,33792,-0.00277764132232526,0.111567582029997,-0.22145010210112,0.215894819456469,0.980138058032598
EPHA2,Ephrin type-A receptor 2,Mental health,X29080.Someone to take to doctor when needed as a child,33869,0.0289010260890868,0.0945085209797544,-0.156335675031232,0.214137727209405,0.75976110905261
EPHA2,Ephrin type-A receptor 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,33897,-0.137276554877572,0.118097085421061,-0.368746842302852,0.0941937325477082,0.245100667857386
EPHA2,Ephrin type-A receptor 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,33821,-0.000107630055497239,0.0879400642151121,-0.172470155917117,0.172254895806122,0.99902349347629
EPHA2,Ephrin type-A receptor 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,33898,-0.077027832355822,0.0991698610147958,-0.271400759944822,0.117345095233178,0.437339758812077
EPHA2,Ephrin type-A receptor 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,33857,0.0567745211715797,0.121365722445854,-0.181102294822294,0.294651337165454,0.639940604720834
EPHA2,Ephrin type-A receptor 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,33862,-0.0365037165252349,0.121983123546531,-0.275590638676436,0.202583205625966,0.764754242440067
EPHA2,Ephrin type-A receptor 2,Mental health,X29086.Experienced a violent or sexual assault,33894,0.140228429082756,0.113761348029989,-0.0827438130560237,0.363200671221535,0.217735416022294
EPHA2,Ephrin type-A receptor 2,Mental health,X29087.Experienced a life-threatening injury or illness,33902,0.363114737819956,0.0801523901748232,0.206016053077303,0.520213422562609,5.96213530993446e-06
EPHA2,Ephrin type-A receptor 2,Mental health,X29088.Experienced a marital separation or divorce,33912,-0.0343242187342766,0.0717804481552728,-0.175013897118611,0.106365459650058,0.632530727605519
EPHA2,Ephrin type-A receptor 2,Mental health,X29089.Experienced the death of a spouse or partner,33918,0.108412307102228,0.0896974278367671,-0.0673946514578354,0.284219265662292,0.226829627467266
EPHA2,Ephrin type-A receptor 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,33903,0.0234968869563336,0.0907305972481988,-0.154335083650136,0.201328857562803,0.795660761091053
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29091.Frequency of drinking alcohol,33918,-0.771844625181976,0.0612825821921565,-0.891958486278603,-0.651730764085349,4.38615522893685e-36
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,32706,-0.631145448518026,0.0766710851000297,-0.781420775314085,-0.480870121721968,2.12550049828888e-16
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,32726,-0.705866926371274,0.07888440856306,-0.860480367154872,-0.551253485587677,4.40477314974403e-19
EPHA2,Ephrin type-A receptor 2,Mental health,X29104.Ever used cannabis,33913,-0.0884144494009142,0.0937037203759685,-0.272073741337812,0.095244842535984,0.345422095696359
EPHA2,Ephrin type-A receptor 2,Mental health,X29108.Ever thought that life not worth living,33860,0.128309337448159,0.0725622221517855,-0.0139126179693401,0.270531292865659,0.0770487882004314
EPHA2,Ephrin type-A receptor 2,Mental health,X29109.Ever contemplated self-harm,33894,0.115833282803446,0.0967111274304023,-0.0737205269601423,0.305387092567035,0.231054372822208
EPHA2,Ephrin type-A receptor 2,Mental health,X29111.Ever self-harmed,33909,0.216774821366801,0.14977112886325,-0.0767765912051685,0.510326233938771,0.147825384877761
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,33901,0.119990173507499,0.101264392272261,-0.0784880353461325,0.318468382361131,0.236079000843874
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33501,-0.0266519380719507,0.028595638802473,-0.0826993901247977,0.0293955139808964,0.351346884277757
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33501,-0.0380428544862041,0.0221263090068871,-0.0814104201397027,0.00532471116729451,0.0855849808146025
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33501,-0.0410962111449929,0.0223504986012037,-0.0849031884033521,0.00271076611336626,0.0659897733213387
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33501,-0.0283850355677706,0.0285528988989221,-0.0843487174096578,0.0275786462741167,0.320190558692314
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,33895,-0.0328132016080529,0.0670401895814744,-0.164211973187743,0.0985855699716368,0.624530494455827
EPHA2,Ephrin type-A receptor 2,Health and medical history,X29153.Pain or discomfort today,33908,0.20712779210227,0.0643385482499206,0.0810242375324261,0.333231346672115,0.00128919137013494
EPHA2,Ephrin type-A receptor 2,Mental health,X29154.Anxiety or depression today,33908,0.0724780152804025,0.076859206147325,-0.0781660287683545,0.223122059329159,0.345706440281876
EPHA2,Ephrin type-A receptor 2,Mental health,X29166.Frequency of confiding in someone close,33668,-0.129619425371858,0.0625186492626108,-0.252155977926575,-0.00708287281714075,0.0381728284102838
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,33875,0.00441634242598687,0.00679940310470477,-0.00891048765923448,0.0177431725112082,0.516018713758608
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,33875,-0.012429950708411,0.00667821657672587,-0.0255192551987937,0.000659353781971739,0.0627374588477115
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,33875,-0.0480570962367097,0.00973814885643318,-0.0671438679953187,-0.0289703244781006,8.15519264996733e-07
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,33875,0.0169438114932471,0.00854311327018212,0.000199309483690142,0.033688313502804,0.0473595782182883
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,33875,-0.0043749139116821,0.0127085551263869,-0.0292836819594005,0.0205338541360363,0.730666331080534
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,33875,0.000743795750845005,0.00668126884291347,-0.0123514911812654,0.0138390826829554,0.9113605874975
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,33875,-0.00290089002368138,0.00744193832261211,-0.0174870891360011,0.0116853090886384,0.696691021168499
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,33875,-0.0181786550946222,0.0104427531439817,-0.0386464512568263,0.0022891410675819,0.0817527859914271
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,33875,-0.0104165339493204,0.0216074063762023,-0.0527670504466768,0.031933982548036,0.629759147059595
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,33875,0.0319140158996871,0.0143768319179445,0.00373542534051587,0.0600926064588583,0.0264545241446096
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,33875,-0.0153341691330156,0.0202484406430874,-0.0550211127934668,0.0243527745274356,0.448888346163677
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,33875,0.0134173378518762,0.0105880465855134,-0.00733523345573005,0.0341699091594824,0.205109524217089
EPHA2,Ephrin type-A receptor 2,Mental health,X29171.Frequency of feeling 'in tune' with people,33765,-0.127831981864279,0.0780484321715124,-0.280806908920443,0.0251429451918855,0.101485820074188
EPHA2,Ephrin type-A receptor 2,Mental health,X29172.Freuency of feeling that lacks companionship,33851,0.210067205239955,0.0693380046433062,0.0741647161390753,0.345969694340836,0.00245534114346214
EPHA2,Ephrin type-A receptor 2,Mental health,X29173.Frequency of feeling left out,33792,0.109308135569762,0.0725521918497444,-0.0328941604557371,0.251510431595261,0.13194349310937
EPHA2,Ephrin type-A receptor 2,Mental health,X29174.Frequency of feeling isolated from others,33824,0.148372739250792,0.0753341928728092,0.000717721220085954,0.296027757281498,0.0489219958185076
EPHA2,Ephrin type-A receptor 2,Mental health,X29175.Tendency to bounce back quickly after hard times,33894,-0.0428876489632456,0.0634527701188985,-0.167255078396287,0.0814797804697954,0.499121480987061
EPHA2,Ephrin type-A receptor 2,Mental health,X29176.Ability to make it through stressful events,33894,0.0564184281191223,0.0612647319898144,-0.0636604465809139,0.176497302819158,0.357128420016907
EPHA2,Ephrin type-A receptor 2,Mental health,X29177.Quick recovery from stressful events,33894,-0.0324474830700207,0.0622682707908419,-0.154493293820071,0.0895983276800296,0.602315072388128
EPHA2,Ephrin type-A receptor 2,Mental health,X29178.Hard to snap back when something bad happens,33894,0.00805883001552272,0.0613773288044642,-0.112240734441227,0.128358394472272,0.895540960927996
EPHA2,Ephrin type-A receptor 2,Mental health,X29179.Comes through difficult times with little trouble,33894,0.0152185065789002,0.062247228813189,-0.10678606189495,0.137223075052751,0.806860621009408
EPHA2,Ephrin type-A receptor 2,Mental health,X29180.Tendency to take a long time to get over setbacks,33894,0.0714599520980804,0.0620573467813996,-0.0501724475934629,0.193092351789624,0.249549684342691
EPHA2,Ephrin type-A receptor 2,Mental health,X29181.General happiness,33840,0.108141285969492,0.0648616738062895,-0.0189875946908352,0.23527016662982,0.0954960495598267
EPHA2,Ephrin type-A receptor 2,Mental health,X29182.Belief that own life is meaningful,33744,-0.0836749663476613,0.0635477405390369,-0.208228537804174,0.0408786051088511,0.187962947637914
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,29446,0.0328101143313626,0.076554684045534,-0.117237066397884,0.182857295060609,0.668244464018539
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2946.Father's age,30472,-0.00345915605247916,0.00625396864831307,-0.0157169346031728,0.00879862249821445,0.580206060547232
EPHA2,Ephrin type-A receptor 2,Health and medical history,X2966.Age high blood pressure diagnosed,30165,-0.0285521590133204,0.00569419742971229,-0.0397127859755564,-0.0173915320510843,5.48466704755788e-07
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,50305,0.000638614937317862,0.00218662227540909,-0.00364716472248395,0.00492439459711968,0.770246576947643
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,50305,-0.0171647869721607,0.00255619823051624,-0.0221749355039726,-0.0121546384403489,1.92004941189729e-11
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30020.Haemoglobin concentration,50305,-0.0428904998731583,0.00277200464788518,-0.0483236289830133,-0.0374573707633034,9.23712174386657e-54
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30030.Haematocrit percentage,50305,-0.0346870397182081,0.00269279370936859,-0.0399649153885706,-0.0294091640478457,7.48852613310098e-38
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30040.Mean corpuscular volume,50305,-0.0165332348445919,0.00214314199025694,-0.0207337931454955,-0.0123326765436883,1.25841951137257e-14
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,50304,-0.021429004455876,0.00214403761598981,-0.025631318183216,-0.0172266907285359,1.77364198655179e-23
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,50304,-0.0150100691346159,0.00209717423635042,-0.0191205306378627,-0.0108996076313691,8.4486898178325e-13
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,50305,0.032100486497167,0.00202556810066662,0.0281303730198604,0.0360705999744735,2.68830296931606e-56
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30080.Platelet count,50305,-0.0175958621509439,0.00215116904341578,-0.0218121534760388,-0.013379570825849,2.97562676592515e-16
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30090.Platelet crit,50305,-0.014016371709523,0.00220367721138603,-0.0183355790438396,-0.00969716437520639,2.04531587815182e-10
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,50305,0.011236266052716,0.0020875760609994,0.00714461697315721,0.0153279151322749,7.41195868868933e-08
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30110.Platelet distribution width,50305,0.00553197941103917,0.00208510174812144,0.00144517998472116,0.00961877883735719,0.00798054367170322
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30120.Lymphocyte count,50267,-0.0136864901668525,0.0021705323714913,-0.0179407336149754,-0.00943224671872953,2.91742293106559e-10
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30130.Monocyte count,50267,0.0119207877616373,0.00219786583391267,0.00761297072716848,0.0162286047961062,5.88684279852211e-08
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30140.Neutrophill count,50267,0.000967609532261541,0.00217168541521884,-0.00328889388156738,0.00522411294609047,0.655921049042486
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30150.Eosinophill count,50267,0.0253341252276011,0.00213341186608953,0.0211526379700656,0.0295156124851366,1.94078099277416e-32
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30160.Basophill count,50267,-0.0197808809595252,0.0380164466851623,-0.0942931164624433,0.0547313545433929,0.602842025170634
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30170.Nucleated red blood cell count,50267,0.26680334205888,0.156101783325903,-0.0391561532598896,0.57276283737765,0.0874328396917871
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30180.Lymphocyte percentage,50267,-0.0141312187398097,0.00214341867195036,-0.0183323193368324,-0.00993011814278697,4.39812701288797e-11
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30190.Monocyte percentage,50267,0.0131282083948272,0.0021685077831061,0.00887793313993929,0.0173784836497152,1.43215832185402e-09
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30200.Neutrophill percentage,50267,0.00262693619328772,0.00212771144146461,-0.00154337823198291,0.00679725061855835,0.216979508590078
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30210.Eosinophill percentage,50267,0.0257357010237409,0.00210769074729139,0.0216046271590498,0.0298667748884321,3.40030613635412e-34
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30220.Basophill percentage,50267,0.000350794408784465,0.00202080255083576,-0.00360997859085363,0.00431156740842256,0.862187771495469
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,50267,0.273662267258247,0.156022212640608,-0.0321412695173457,0.579465804033839,0.0794431345551565
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30240.Reticulocyte percentage,49828,-0.00194852004786619,0.00222456123271556,-0.00630866006398869,0.00241161996825631,0.381086124953483
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30250.Reticulocyte count,49828,-0.00576992780144279,0.00229844516780579,-0.0102748803303421,-0.00126497527254344,0.0120669383299928
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30260.Mean reticulocyte volume,49828,0.0102154207567771,0.00212621224149653,0.00604804476344392,0.0143827967501103,1.56012038644208e-06
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30270.Mean sphered cell volume,49828,-0.00613420236425866,0.00215101844326738,-0.0103501985130627,-0.0019182062154546,0.004351212106832
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30280.Immature reticulocyte fraction,49828,0.00388854289097806,0.00224639111956554,-0.000514383703370387,0.00829146948532651,0.0834607547971275
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,49828,9.1422236062982e-05,0.00228673655934926,-0.00439058142026156,0.00457342589238752,0.968109905766656
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30300.High light scatter reticulocyte count,49828,-0.00300306264803112,0.00234524337574848,-0.00759973966449814,0.0015936143684359,0.200384269920033
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30500.Microalbumin in urine,31924,0.0493319564559061,0.00457930222672516,0.0403565240915248,0.0583073888202874,7.28274360438612e-27
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,50352,0.00872290111645968,0.00222602896564396,0.00435988434379752,0.0130859178891218,8.92961935181762e-05
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30520.Potassium in urine,50304,-0.00539284372342616,0.00207013990564964,-0.00945031793849946,-0.00133536950835287,0.00919101129430593
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30530.Sodium in urine,50276,-0.00114229940594326,0.00218365155848699,-0.00542225646057776,0.00313765764869124,0.600899187268415
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30600.Albumin,47627,-0.0644005110641645,0.00225789102849693,-0.0688259774800185,-0.0599750446483105,6.73296101979591e-176
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30610.Alkaline phosphatase,49918,0.0685982194937021,0.00213787576573316,0.0644079829928651,0.0727884559945391,1.71476450623875e-221
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30620.Alanine aminotransferase,49928,0.0051620207404019,0.00227737409301914,0.000698367518084381,0.00962567396271943,0.0234196732628433
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30630.Apolipoprotein A,47412,-0.0312176614383286,0.00250205154951782,-0.0361216824753835,-0.0263136404012737,1.3033617060047e-35
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30640.Apolipoprotein B,49820,-0.0202649697583138,0.00216789605955945,-0.0245140460350503,-0.0160158934815773,9.66692769678352e-21
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30650.Aspartate aminotransferase,49851,0.0268788552591868,0.00219404023724279,0.022578536394191,0.0311791741241827,2.07940343588303e-34
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30660.Direct bilirubin,44279,0.0020302415915422,0.00244702717744255,-0.00276593167624519,0.00682641485932959,0.406731550765148
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30670.Urea,49913,0.0657354385909425,0.00223311442664848,0.0613585343147115,0.0701123428671735,2.5646385715972e-187
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30680.Calcium,47633,-0.0225277127513249,0.00220016664565236,-0.0268400393768035,-0.0182153861258462,1.49424701104584e-24
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30690.Cholesterol,49927,-0.0245106013180669,0.00222994421141608,-0.0288812919724424,-0.0201399106636914,4.8507025200361e-28
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30700.Creatinine,49920,0.126333454309538,0.00235551781547532,0.121716639391207,0.13095026922787,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30710.C-reactive protein,49863,0.0085628965041088,0.00238607892011315,0.00388618182068703,0.0132396111875306,0.000332969241340184
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30720.Cystatin C,49921,0.201837043160227,0.00208251123811896,0.197755321133514,0.20591876518694,0
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30730.Gamma glutamyltransferase,49923,-0.00760087005576761,0.00222942426290515,-0.0119705416110617,-0.00323119850047351,0.00065220649878635
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30740.Glucose,47606,-0.00754665899199234,0.00238856754462934,-0.0122282513794658,-0.00286506660451883,0.00158247951993814
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),49772,0.0143109313380201,0.00240866533633842,0.00958994727879678,0.0190319153972434,2.86227270341123e-09
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30760.HDL cholesterol,47619,-0.0355073745631718,0.00263616198434423,-0.0406742520524864,-0.0303404970738571,3.38702473135871e-41
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30770.IGF-1,49782,-0.0078289919447741,0.00218685298519254,-0.0121152237957515,-0.00354276009379672,0.000344201436321788
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30780.LDL direct,49876,-0.0186891308374138,0.00217798053764853,-0.0229579726912049,-0.0144202889836226,9.93823045219974e-18
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30790.Lipoprotein A,44829,0.000384363269139448,0.00236282097846535,-0.00424676584865264,0.00501549238693153,0.870778821986688
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30810.Phosphate,47585,0.0201433269506253,0.0023799396133211,0.015478645308516,0.0248080085927347,2.7395699517193e-17
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30830.SHBG,47368,0.0341914857798746,0.00248665463367544,0.0293176426978707,0.0390653288618785,7.53728239563979e-43
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30840.Total bilirubin,49833,-0.010419849016983,0.00219396118539353,-0.0147200129403543,-0.0061196850936117,2.05204519044956e-06
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30850.Testosterone,45560,-0.0181561644292909,0.00382566483477199,-0.025654467505444,-0.0106578613531378,2.08956663388325e-06
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30860.Total protein,47624,-0.0329320209909156,0.00223463180683496,-0.0373118993323121,-0.0285521426495191,6.20340878766181e-49
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30870.Triglycerides,49918,0.019207836211576,0.00242085282081107,0.0144629646827863,0.0239527077403657,2.20293216623132e-15
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30880.Urate,49893,0.0532414110626414,0.00263791423733441,0.0480710991574659,0.0584117229678168,6.96746121463125e-90
EPHA2,Ephrin type-A receptor 2,Blood and urine assays,X30890.Vitamin D,48452,-0.00300091557197936,0.00237848700428055,-0.00766275010036923,0.00166091895641052,0.207072269978806
EPHA2,Ephrin type-A receptor 2,Physical measures,X3137.Number of measurements made,48841,0.101754034889954,0.0434375503351565,0.0166164362330469,0.18689163354686,0.0191611715018171
EPHA2,Ephrin type-A receptor 2,Physical measures,X3143.Ankle spacing width,39618,0.022528271971599,0.00372010309999423,0.0152368698956104,0.0298196740475877,1.43002166737527e-09
EPHA2,Ephrin type-A receptor 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",39617,-0.0130040940836497,0.00302924143568071,-0.0189414072975839,-0.0070667808697155,1.77485480283826e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X3146.Speed of sound through heel,39618,-0.0208669107219446,0.00291562038224117,-0.0265815266711373,-0.0151522947727519,8.62817926438546e-13
EPHA2,Ephrin type-A receptor 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",39618,-0.018767915655397,0.00295431763548199,-0.0245583782209417,-0.0129774530898523,2.17590179301952e-10
EPHA2,Ephrin type-A receptor 2,Physical measures,X3148.Heel bone mineral density (BMD),39616,-0.0188983488796173,0.00294693855658545,-0.0246743484505248,-0.0131223493087098,1.47027786950213e-10
EPHA2,Ephrin type-A receptor 2,Health and medical history,X3526.Mother's age at death,40349,-0.00547644345231191,0.00283607122850514,-0.011035143060182,8.22561555581742e-05,0.0535012512055743
EPHA2,Ephrin type-A receptor 2,Health and medical history,X3581.Age at menopause (last menstrual period),39764,-0.0114169182465307,0.00281168494847104,-0.016927820745534,-0.00590601574752746,4.92059856249078e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29985,0.00191744606030395,0.00449513932133405,-0.00689302700951078,0.0107279191301187,0.669716524636635
EPHA2,Ephrin type-A receptor 2,Physical measures,X4100.Ankle spacing width (left),33057,0.0174048693380614,0.00483362108282531,0.00793097201572383,0.026878766660399,0.000319034146542318
EPHA2,Ephrin type-A receptor 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),33055,-0.0111404896290954,0.00396770064832599,-0.0189171828998144,-0.0033637963583765,0.00499943162425592
EPHA2,Ephrin type-A receptor 2,Physical measures,X4103.Speed of sound through heel (left),33057,-0.0196863503757297,0.00385845708810419,-0.0272489262684139,-0.0121237744830454,3.43025783448656e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",33057,-0.017165168622798,0.00389436181648808,-0.0247981177831146,-0.00953221946248134,1.05742566756269e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),33055,-0.0174413338413588,0.00388288284427363,-0.0250517842161351,-0.00983088346658245,7.15277736449966e-06
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",33057,-0.0171611198462508,0.00389412761456661,-0.0247936099708014,-0.00952862972170023,1.0612042725035e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X4119.Ankle spacing width (right),33058,0.0163133327136232,0.0047750223584204,0.00695428889111922,0.0256723765361272,0.000637510948087633
EPHA2,Ephrin type-A receptor 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),33058,-0.0112691079829199,0.00396770764788567,-0.0190458149727758,-0.00349240099306396,0.0045190168970304
EPHA2,Ephrin type-A receptor 2,Physical measures,X4122.Speed of sound through heel (right),33058,-0.0192241308434368,0.00387196403838193,-0.0268131803586653,-0.0116350813282082,7.0036653746209e-07
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",33058,-0.016956896458783,0.00390189636579359,-0.0246046133357385,-0.00930917958182757,1.4035731950542e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),33055,-0.0168787140263373,0.00389467880550527,-0.0245122844851276,-0.00924514356754695,1.48231512931826e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",33058,-0.0169537312857748,0.00390191363065017,-0.0246014820018492,-0.00930598056970048,1.40888163064371e-05
EPHA2,Ephrin type-A receptor 2,Physical measures,X4194.Pulse rate,33317,0.0056206176754915,0.00378338590069675,-0.00179481868987413,0.0130360540408571,0.137419144114624
EPHA2,Ephrin type-A receptor 2,Physical measures,X4195.Pulse wave reflection index,33317,-3.56083510832425e-05,0.00379168998096031,-0.00746732071376546,0.00739610401159897,0.992507263291843
EPHA2,Ephrin type-A receptor 2,Physical measures,X4196.Pulse wave peak to peak time,33314,-0.00238286387788117,0.00346545860642163,-0.00917516274646757,0.00440943499070522,0.491720060418096
EPHA2,Ephrin type-A receptor 2,Physical measures,X4198.Position of the pulse wave peak,33317,-0.00126011442846271,0.00334243674952886,-0.00781129045753927,0.00529106160061385,0.706179121674912
EPHA2,Ephrin type-A receptor 2,Physical measures,X4199.Position of pulse wave notch,33317,0.003757024311861,0.00373233944529041,-0.00355836100090821,0.0110724096246302,0.314147884714588
EPHA2,Ephrin type-A receptor 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,33317,0.00134360926846426,0.00334842352430769,-0.00521930083917881,0.00790651937610732,0.688233798852659
EPHA2,Ephrin type-A receptor 2,Physical measures,X4269.Number of triplets attempted (left),33220,-0.165765829331087,0.182678699463429,-0.523816080279409,0.192284421617234,0.364211092532405
EPHA2,Ephrin type-A receptor 2,Physical measures,X4270.Volume level set by participant (left),33133,-0.00140626142505024,0.0596100050975942,-0.118241871416335,0.115429348566234,0.981179369500476
EPHA2,Ephrin type-A receptor 2,Physical measures,X4276.Number of triplets attempted (right),33221,-0.280416023271346,0.173130580283172,-0.619751960626363,0.05891991408367,0.10533718990306
EPHA2,Ephrin type-A receptor 2,Physical measures,X4277.Volume level set by participant (right),33120,-0.0532925136070848,0.0599704919791438,-0.170834677886207,0.0642496506720371,0.374218245538018
EPHA2,Ephrin type-A receptor 2,Cognitive function,X4288.Time to answer,33390,-0.0023939661073897,0.00425215150886124,-0.0107281830647577,0.00594025084997834,0.573448235724068
EPHA2,Ephrin type-A receptor 2,Cognitive function,X4290.Duration screen displayed,33390,0.0112263243337337,0.00376043999336956,0.0038558619467294,0.0185967867207381,0.00283997707467888
EPHA2,Ephrin type-A receptor 2,Physical measures,X46.Hand grip strength (left),51091,-0.0438796665011343,0.00312957028332639,-0.050013624256454,-0.0377457087458146,1.67014258675415e-44
EPHA2,Ephrin type-A receptor 2,Physical measures,X47.Hand grip strength (right),51097,-0.0427145531289941,0.00311697792046086,-0.0488238298530974,-0.0366052764048908,1.34332556989136e-42
EPHA2,Ephrin type-A receptor 2,Physical measures,X48.Waist circumference,51179,0.000437905230948036,0.004196337884407,-0.00778691702248969,0.00866272748438576,0.916889097940544
EPHA2,Ephrin type-A receptor 2,Health and medical history,X4803.Tinnitus,33234,0.09915834211685,0.0709770530008631,-0.0399566817648418,0.238273365998542,0.162434480447278
EPHA2,Ephrin type-A receptor 2,Working and living environment,X4825.Noisy workplace,33361,0.0877683490652215,0.101984571044578,-0.112121410182152,0.287658108312595,0.389479242412086
EPHA2,Ephrin type-A receptor 2,Working and living environment,X4836.Loud music exposure frequency,33307,0.0577557995204769,0.120643227459184,-0.178704926299524,0.294216525340478,0.632140967597042
EPHA2,Ephrin type-A receptor 2,Physical measures,X49.Hip circumference,51175,0.00437354696447242,0.00355615628792092,-0.00259651935985258,0.0113436132887974,0.218763249005404
EPHA2,Ephrin type-A receptor 2,Physical measures,X50.Standing height,51173,0.0200428295206854,0.00290509377070176,0.0143488457301099,0.0257368133112608,5.34615100675048e-12
EPHA2,Ephrin type-A receptor 2,Health and medical history,X5057.Number of older siblings,32342,-0.0587727700031285,0.0633421448026383,-0.1829233738163,0.0653778338100426,0.353507537587265
EPHA2,Ephrin type-A receptor 2,Physical measures,X51.Seated height,51057,0.00927043683609557,0.00291714711463588,0.00355282849140926,0.0149880451807819,0.00148509390152056
EPHA2,Ephrin type-A receptor 2,Eye measures,X5181.Ever had eye surgery,30463,-0.0205127092312139,0.144395826158899,-0.303528528502657,0.262503110040229,0.887038260771889
EPHA2,Ephrin type-A receptor 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),30446,-0.00418184460440796,0.0043176521466485,-0.012644442811839,0.0042807536030231,0.332810848456178
EPHA2,Ephrin type-A receptor 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),30448,0.00095827747070518,0.00426001926834078,-0.00739136029524276,0.00930791523665312,0.822028368773264
EPHA2,Ephrin type-A receptor 2,Eye measures,X5190.Duration at which refractometer first shown (right),30376,-0.000366170262623652,0.00428225133802969,-0.00875938288516185,0.00802704235991455,0.931859772744372
EPHA2,Ephrin type-A receptor 2,Eye measures,X5193.Duration at which refractometer first shown (left),30377,0.000161380196886618,0.00430297777637582,-0.00827245624480998,0.00859521663858322,0.970084170047542
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5199.logMAR, initial (right)",30427,0.139389461510805,0.0770083159798522,-0.0115468378097052,0.290325760831315,0.0703371354431094
EPHA2,Ephrin type-A receptor 2,Eye measures,X5200.Final number of letters displayed (right),30427,-0.381802489567325,0.496856330270505,-1.35564089689751,0.592035917762864,0.442258342273909
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5201.logMAR, final (right)",30378,0.00769006494780635,0.00449520038382972,-0.0011205278044999,0.0165006577001126,0.0871836825254804
EPHA2,Ephrin type-A receptor 2,Eye measures,X5202.Number of rounds to result (right),30427,0.041524392162619,0.0715437872194319,-0.0987014307874675,0.181750215112705,0.561663270505608
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5206.logMAR, initial (left)",30425,0.0409685475557782,0.0758347432756406,-0.107667549264477,0.189604644376034,0.589055441379764
EPHA2,Ephrin type-A receptor 2,Eye measures,X5207.Final number of letters displayed (left),30425,-0.0772597332140222,0.448307846571939,-0.955943112495023,0.801423646066978,0.863178957644167
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5208.logMAR, final (left)",30364,0.00406174551576313,0.00445163274821148,-0.00466345467073136,0.0127869457022576,0.361586433888823
EPHA2,Ephrin type-A receptor 2,Eye measures,X5209.Number of rounds to result (left),30423,-0.000303240305125696,0.0717228241454038,-0.140879975630117,0.140273495019866,0.996626737849417
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",30139,-0.00755415253000597,0.00440286579494973,-0.0161837694881074,0.00107546442809549,0.086264956106686
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",30139,-0.00929998258097701,0.00444402146031837,-0.018010264643201,-0.000589700518753006,0.0364205779601248
EPHA2,Ephrin type-A receptor 2,Eye measures,X5256.Corneal hysteresis (right),30139,-0.000430533804693625,0.00440738651276117,-0.00906901136970552,0.00820794376031827,0.922186184011453
EPHA2,Ephrin type-A receptor 2,Eye measures,X5257.Corneal resistance factor (right),30139,-0.00519030574095174,0.00441865525454866,-0.0138508700398671,0.00347025855796364,0.240190080268627
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",30139,-0.00884530334245341,0.0043886164398381,-0.0174469915645361,-0.00024361512037074,0.0438981192466442
EPHA2,Ephrin type-A receptor 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",30139,-0.00809280734267417,0.00437269731112512,-0.0166632940724794,0.000477679387131068,0.0642561044053301
EPHA2,Ephrin type-A receptor 2,Eye measures,X5264.Corneal hysteresis (left),30139,0.00300481409232718,0.00447885300923917,-0.00577373780578158,0.0117833659904359,0.50231836518098
EPHA2,Ephrin type-A receptor 2,Eye measures,X5265.Corneal resistance factor (left),30139,-0.00213492485686777,0.00442927847050058,-0.0108163106590489,0.00654646094531337,0.629822468596818
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29738,0.761662219459023,0.331809002216279,0.111316575115116,1.41200786380293,0.0217443883767088
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51095,0.0626300615495018,0.012204362521137,0.0387095110080732,0.0865506120909304,2.89033464379895e-07
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51095,0.0685140358076165,0.0125714477225453,0.0438739982714277,0.0931540733438052,5.08241882747816e-08
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51095,0.0421549891953996,0.0325269346949855,-0.021597802806772,0.105907781197571,0.194985844711826
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51095,-0.0120895839180392,0.00533645140252346,-0.0225490286669852,-0.0016301391690932,0.0234916909741254
EPHA2,Ephrin type-A receptor 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51095,-0.0064357781297439,0.00487697550183133,-0.0159946501133333,0.0031230938538455,0.186971636435399
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",36795,-0.0232186590202604,0.00622827117347316,-0.0354260705202678,-0.011011247520253,0.000193909407518026
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",36795,0.000197073366336238,0.0156305489398254,-0.0304388025557215,0.030832949288394,0.989940567926018
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",36795,0.00836298581693436,0.0122272350515995,-0.0156023948842007,0.0323283665180694,0.49401088233058
EPHA2,Ephrin type-A receptor 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",36795,0.00842616401114108,0.0074896449335758,-0.00625354005866749,0.0231058680809497,0.260593176001624
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51170,0.00988130787961879,0.0100053639080453,-0.00972920538015003,0.0294918211393876,0.323357016322742
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51170,0.00988130787961879,0.0100053639080453,-0.00972920538015003,0.0294918211393876,0.323357016322742
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51170,-0.0111094576128312,0.00801756718917002,-0.0268238893036044,0.00460497407794206,0.165868583253912
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51170,-0.0105698769314802,0.0125518183981109,-0.0351714409917776,0.0140316871288172,0.399739935290877
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51170,0.0340498985138205,0.0309864053390807,-0.0266834559507777,0.0947832529784187,0.271836544108936
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51170,0.00707795638287371,0.0212611265200222,-0.0345938515963698,0.0487497643621172,0.739207859395464
EPHA2,Ephrin type-A receptor 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51170,-0.019491985826516,0.0347334112903784,-0.0875694719556577,0.0485855003026256,0.574673849445194
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51095,0.0207537769895828,0.00645522367105877,0.00810153859430762,0.033406015384858,0.00130583574170009
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51095,0.0165459200133877,0.0107949343133496,-0.00461215124077755,0.037703991267553,0.125349692983722
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51095,-0.00169625925242854,0.00570601627593594,-0.012880051153263,0.00948753264840589,0.766258447420206
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51095,0.0224350561964934,0.0105862683182545,0.00168597029271459,0.0431841421002722,0.0340777141394333
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51095,0.00154231092960704,0.0103357564815257,-0.0187157717741834,0.0218003936333974,0.881380454769843
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51095,0.058496008803971,0.00578467579069114,0.0471580442542163,0.0698339733537256,5.38741329654102e-24
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,31613,0.109353803960535,0.0246817444774997,0.0609775847846357,0.157730023136435,9.53900051463464e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,31613,0.03694104887493,0.0160585077228015,0.0054663737382391,0.0684157240116208,0.0214539719519236
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,31613,0.141803683240048,0.0205090804059446,0.101605885644397,0.1820014808357,5.11127357769288e-12
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,31613,-0.0270470548072208,0.0182308502746511,-0.062779521345537,0.00868541173109528,0.137962495967759
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51082,0.0125201640153508,0.0158159088071633,-0.0184790172466893,0.0435193452773909,0.42859028078182
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51082,-0.0139204321362158,0.026903971204445,-0.0666522156969279,0.0388113514244964,0.604873022664739
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51082,0.0760712831517399,0.0431526627263332,-0.00850793579187327,0.160650502095353,0.0779387784747438
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51082,-0.0549863070687075,0.042099263435621,-0.137500863402525,0.0275282492651097,0.191526126438051
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51082,0.0240848838944126,0.0132168231670468,-0.00182008951299912,0.0499898573018244,0.06842221361988
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51082,0.0279776173434778,0.0186469902049056,-0.00857048345813717,0.0645257181450928,0.13352721140916
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51082,0.0142080465125379,0.0092845820346952,-0.00398973427546465,0.0324058273005405,0.125958346901213
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33605,0.102144955515963,0.0143729677277944,0.0739739387694864,0.13031597226244,1.27703974648686e-12
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33605,0.0414526437863825,0.0168403548846501,0.00844554821246837,0.0744597393602967,0.0138537964780518
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33605,0.10847191392897,0.0216469242834248,0.066043942333457,0.150899885524482,5.51720255260628e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33605,0.0128854242251985,0.00755915620520791,-0.00193052193700904,0.027701370387406,0.0883008514215046
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",37064,0.0444566188282965,0.00768750004545625,0.0293891187392022,0.0595241189173907,7.51315872849559e-09
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",37064,-0.0336265787568877,0.00671949399675517,-0.0467967869905278,-0.0204563705232476,5.68118550766873e-07
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",37064,-0.00165100202878077,0.00629903882126957,-0.0139971181184691,0.0106951140609076,0.793245695645159
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",37064,0.00994054148355304,0.0151911097794617,-0.0198340336841919,0.039715116651298,0.512888146487798
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",37064,0.0579535450155862,0.00906583255618825,0.0401845132054572,0.0757225768257151,1.68920170623294e-10
EPHA2,Ephrin type-A receptor 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",37064,-0.00634713568778178,0.0104925309611651,-0.0269124963716654,0.0142182249961018,0.54524342563061
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51095,-0.000567970822057792,0.0141655938483653,-0.0283325347648538,0.0271965931207382,0.968017613213825
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51095,-0.00227004922539656,0.00907926332887401,-0.0200654053499896,0.0155253068991965,0.802569396876334
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51095,0.0314773103857736,0.0353002863394409,-0.0377112508395306,0.100665871611078,0.372561122048972
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51095,0.000985894795559911,0.00893328088797309,-0.0165233357448673,0.0184951253359872,0.912123115383286
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51095,-0.0170880003355016,0.0107261859446472,-0.0381113247870102,0.0039353241160069,0.111147248355332
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51095,0.0485127172528559,0.0120170911500227,0.0249592185988114,0.0720662159069004,5.42957508877895e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51095,-0.000880348010842235,0.00426197018518792,-0.00923380957381056,0.00747311355212609,0.836355914208474
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28655,0.0628123335772677,0.0152209778260549,0.0329792170382001,0.0926454501163354,3.75140830512864e-05
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28655,0.0523355880315357,0.0200762909580122,0.0129860577538318,0.0916851183092397,0.009170599290531
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28655,-0.0483647204839573,0.0133139997954,-0.0744601600829412,-0.0222692808849733,0.000283904923605503
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28655,0.0111659542312671,0.0120720922293463,-0.0124953465382517,0.0348272550007859,0.35505049766875
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51210,0.00424193397982673,0.00486317432438679,-0.00528988769597137,0.0137737556556248,0.383076450327369
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51210,-0.00103979677354542,0.0130359314266646,-0.0265902223698081,0.0245106288227173,0.936425630312115
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51210,0.00394943030789001,0.00474085701462837,-0.00534264944078159,0.0132415100565616,0.404816903759629
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51210,0.0294922816743822,0.00472938757252084,0.0202226820322413,0.0387618813165231,4.55719758306181e-10
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51210,0.020661258543259,0.00683060836690891,0.00727326614411756,0.0340492509424005,0.00249029446830319
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51210,0.0254549235114983,0.00605196512820218,0.013593071860222,0.0373167751627746,2.60707318315689e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51210,0.0229392261329484,0.00507528962971278,0.0129916584587114,0.0328867938071855,6.21670010904365e-06
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51210,0.139062546876529,0.0137788427486647,0.112056015089146,0.166069078663911,6.5829676925252e-24
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,42820,-0.0160387060317152,0.00497454684440389,-0.0257888178467469,-0.0062885942166836,0.0012656609874021
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,42820,-0.0220472559949657,0.00551476887732438,-0.0328562029945215,-0.0112383089954099,6.41684302646619e-05
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,42820,0.0245570575094659,0.00553379357775092,0.0137108220970741,0.0354032929218577,9.14740088200332e-06
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,42820,-0.00838682387184044,0.00708596075162395,-0.0222753069450234,0.0055016592013425,0.23659342411205
EPHA2,Ephrin type-A receptor 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,42820,0.00304010519603264,0.00500965301261687,-0.00677881470869643,0.0128590251007617,0.543958325562367
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,50976,-0.00786571980651653,0.00512092382945514,-0.0179027305122486,0.00217129089921555,0.12455122756252
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,50976,-0.0151430728193851,0.00412197823251882,-0.023222150155122,-0.00706399548364822,0.000239496853927703
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,50976,-0.00662814747098516,0.00450637465156821,-0.0154606417880589,0.00220434684608853,0.14134677227489
EPHA2,Ephrin type-A receptor 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,50976,-0.00284902545000025,0.00987168012126594,-0.0221975184876815,0.016499467587681,0.772885210172613
EPHA2,Ephrin type-A receptor 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),50988,-0.0403910069904961,0.00464472004365937,-0.0494946582760684,-0.0312873557049237,3.62936164627717e-18
EPHA2,Ephrin type-A receptor 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,50988,-0.0197908489496385,0.00837313070449795,-0.0362021851304545,-0.00337951276882255,0.0181048222431729
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51095,-0.0181421296601215,0.00445359333841362,-0.0268711726034122,-0.00941308671683075,4.64270993927906e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51095,-0.022117994444845,0.00505329761669482,-0.0320224577735669,-0.0122135311161232,1.2081317887105e-05
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51095,0.0112159507265832,0.00659651432123031,-0.00171321734302824,0.0241451187961946,0.0890891049255156
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51095,-0.0131513209917947,0.0095236886229777,-0.031817750692831,0.00551510870924157,0.16731937555284
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51095,0.0569175815954656,0.00985836933595484,0.0375951776969941,0.0762399854939371,7.84895967523537e-09
EPHA2,Ephrin type-A receptor 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51095,-0.00392695049248128,0.0127971947695341,-0.029009452240768,0.0211555512558055,0.758952137968786
EPHA2,Ephrin type-A receptor 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",39618,-0.0187671979071775,0.00295431405134929,-0.0245576534478221,-0.0129767423665329,2.17922414841704e-10
EPHA2,Ephrin type-A receptor 2,Physical activities,X864.Number of days or week walked 10+ minutes,50597,-0.0737303675114971,0.0346013923113792,-0.1415490964418,-0.00591163858119391,0.0331108294523726
EPHA2,Ephrin type-A receptor 2,Physical activities,X874.Duration of walks,46667,-0.00165953122811527,0.0022602627138001,-0.00608964614716347,0.00277058369093293,0.462822108326313
EPHA2,Ephrin type-A receptor 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,49559,-0.065585889501972,0.0336394400515452,-0.131519192003001,0.000347412999056648,0.0512262914672652
EPHA2,Ephrin type-A receptor 2,Physical activities,X894.Duration of moderate activity,43588,-0.0111868151530512,0.0414700350826134,-0.0924680839149736,0.0700944536088711,0.787350431926972
EPHA2,Ephrin type-A receptor 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,30243,-4.70664821749564e-06,0.00445116934266415,-0.00872899855983923,0.00871958526340424,0.999156356714433
EPHA2,Ephrin type-A receptor 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,49549,-0.168441782408843,0.0350238502686329,-0.237088528935364,-0.0997950358823224,1.52303447209256e-06
EPHA2,Ephrin type-A receptor 2,Physical activities,X914.Duration of vigorous activity,37670,0.00636575359229199,0.00290344285786255,0.000675005590881392,0.0120565015937026,0.0283619083366119
